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ABSTRACT 
Growing Up POMC: Pro-opiomelanocortin in the Developing Brain 
Stephanie Louise Padilla 
 
Neurons in the arcuate nucleus of the hypothalamus (ARH) play a central role in the 
regulation of body weight and energy homeostasis. ARH neurons directly sense nutrient and 
hormonal signals of energy availability from the periphery and relay this information to 
secondary nuclei targets, where signals of energy status are integrated to regulate behaviors 
related to food intake and energy expenditure.  Transduction of signals related to energy status 
by Pro-opiomelanocortin (POMC) and neuropeptide-Y/agouti-related protein (NPY/AgRP) 
neurons in the ARH exert opposing influences on secondary neurons in central circuits 
regulating energy balance. My thesis research focused on the developmental events regulating 
the differentiation and specification of cell fates in the ARH.  
My first project was designed to characterize the ontogeny of Pomc- and Npy-expressing 
neurons in the developing mediobasal hypothalamus (Chapter 2).  These experiments led to the 
unexpected finding that during mid-gestation, Pomc is broadly expressed in the majority of 
newly-born ARH neurons, but is subsequently down-regulated during later stages of 
development as cells acquire a terminal cell identity. Moreover, these studies demonstrated that 
most immature Pomc-expressing progenitors subsequently differentiate into non-POMC 
neurons, including a subset of functionally distinct NPY/AgRP neurons.  
The second aspect of my work focused on characterizing Pomc-expressing progenitors 
throughout the brain (Chapter 3). Similar to findings in Chapter 2, Pomc was broadly expressed 
in many aspects of the developing brain and subsequently down-regulated as cells further 
differentiated into non-Pomc terminal identities. In the CNS, the percentage of POMC neurons 
derived from Pomc-expressing progenitors are marginal. These findings are of general 
importance to the field of energy homeostasis research, because many genetically targeted 
functional manipulations of POMC cells have been induced during early development, a time in 
which Pomc is expressed in many cells that will not persist into a POMC terminal identity. The 
off target consequences of these manipulations have yet to be considered. Our work will provide 
the foundational evidence for potential confounds of targeted genetic POMC manipulations and 
may help to explain some of the unexpected phenotypes that have arisin using a BAC 
transgenic Pomc-Cre reagent. 
My current research efforts are focused on elucidating the molecular mechanism regulating 
differentiation and cell fate specification in the ARH during gestation and the early postnatal 
period (Chapter 4). Consistent with the identification of Pomc transcriptional activity during 
embryogenesis, functional POMC-processing products (β-endorphin and α-melanocyte-
stimulating hormone) are also detected in embryonic hypothalamic extracts (at embryonic day 
(E) 13.5 and E15.5, respectively). The presence of POMC-derived peptides in the embryo, prior 
to the establishment of circuits regulating food intake, may be involved in the local differentiation 
events. Preliminary loss-of-function studies are underway to determine the role of POMC-
derived peptides in differentiation of hypothalamic terminal fates. Early results from this work 
indicate that both β-endorphin and α-melanocyte-stimulating hormone are critical to the 
differentiation of the Pomc lineage. The goal of this work is to define the developmental origins 
of critical components of neuronal circuits that determine body weight. Evidence in the literature 
supports that maternal signals influence these events, our studies may provide a means to the 
design of effective strategies to reduce transmission of signals that increase susceptibility to 
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CHAPTER 1: BACKGROUND OVERVIEW 
Body Weight Homeostasis and the Sensation of Hunger 
Thermodynamics of living systems must accommodate the constant exchange of mass and 
energy from the environment. While open systems cannot achieve flat-line equilibrium, they 
instead fluctuate about threshold levels of dynamic equilibrium referred to as homeostasis. One 
example of homeostatic regulation occurs in the cellular supply of energy. The specific energy 
charge of most cells is maintained at a ratio of ATP:ADP equaling 10:1 (Hardie and Hawley, 
2001). This relationship is used as a sensor of the cell's energy availability; in cases when the 
ratio is low, catabolic oxidation pathways are activated to replenish levels of ATP. Conversely, 
when the ratio is high, excess ATP can either be utilized for mechanical work or stored via 
anabolic metabolism. This process of homeostasis, the fluctuation around a "set-point" or 
"threshold", is a means of regulation for biologically open systems. In mammals, homeostatic 
regulation maintains cellular energy charge, blood glucose levels, the insulin:glucagon ratio, 
bone density, body weight, temperature, pH, etc. Biological systems utilize sensor molecules 
(relative to each unique homeostatic system) to initiate perpetual feedback regulation about 
each threshold.   
Human body weight, over the course of one year, is relatively constant (Leibel et al., 1995). 
The sensor system involved in maintaining body weight is complex and the details remain 
somewhat unresolved. Homeostasis of body weight or a certain percent body fat is constantly 
adjusted by alterations in food intake and energy expenditure. If the percent body fat of a 
subject is relatively low, increasing food intake relative to energy expenditure will replenish 
stores. Conversely, decreasing energy consumption relatively to energy expenditure serves as 
a means to restore body weight homeostasis when fat stores are ample. Hunger, satiety and 
energy expenditure are the output measures that determine body weight, but critically important 
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to this flux are the input signals that coordinate this response according to energy availability, 
thus beginning the early investigations into the sensations of hunger.  
At the turn of the twentieth century Babinski-Frohlich syndrome was first described in 
children with rare tumors found at the base of the brain just anterior to the brain stem who 
presented with hyperphagia, were obese and had retarded puberty (Bruch, 1993). Based on 
such cases, it was hypothesized that this area of the brain (in and around the hypothalamus) 
may be responsible for body weight regulation and feeding behavior. At the time, researchers 
lacked the tools needed to thoroughly investigate this observation. 
At University College London, Horsley and Clark invented a stereotactic apparatus, an 
instrument used to three dimensionally map and target precise regions of the brain. This device, 
assembled on the head of an animal model, provided a novel tool to test hypotheses related to 
physiology of the brain. Using this technology, the first hypothalamic lesion experiments were 
performed to investigate the role of the hypothalamus in the sensation of hunger. Data from 
numerous labs in the 40s and 50s found that bilateral lesions administered to the mediobasal 
hypothalamus of rats resulted in hyperphagia induced obesity (Anand BK, 1951; Hervey, 1959; 
Hetherington AW, 1940). Lesioned animals became “voracious,” eating approximately 30 
percent more kcal/day compared to controls (Hervey, 1959). This work established the 
importance of central hypothalamic signaling in the determination of body weight and opened 
the field to explore the afferent signaling factors underlying this specific motor output.  
G.R. Hervey, a scientist at Cambridge, proposed that blood born substances were the 
source of hypothalamic input responsible for determining satiety. He predicted that circulating 
satiety signals would increase in hypothalamic-lesioned obese animals, and that their 
consequent weight gain was the result of damaged sensing cells in the hypothalamus. Using 
parabiosis technology – in which animals were surgically fastened together (parabiosed), 
sharing a plasma volume exchange of ~0.3 to 2.1 percent per minute with the conjoined animal 
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– Hervey investigated circulating blood factors in hypothalamic-lesioned animals. Upon 
parabiosis of two wild-type animals, one was subjected to a bilateral hypothalamic lesion, while 
the other not. Of these lesioned/non-lesioned parabiosed pairs, the lesioned animals became 
obese, while the non-lesioned animals became “listless, inactive, thin and presented a starved 
appearance.” Upon sacrifice (30 days following lesioning), the non-lesioned animals weighed 
approximately 25 percent less than littermate controls (Hervey, 1959). These experiments 
supported Hervey’s hypothesis that blood born satiety signals were one source of afferent 
inputs to the hypothalamus responsible for mediating bodyweight. 
These early lesion experiments left the field eager to discover the responsible circulating 
satiety signal/s. In the 1950’s Gordon Kennedy proposed that because adipose levels varied 
among lesioned animals, that the adipose tissue was the source of the elusive satiety signal 
(Kennedy, 1953). However, beyond this idea, Kennedy did not perform experiments to test his 
hypothesis. 
In the 1960s, Doug Coleman performed a seminal set of experiments which provided the 
foundation for the ultimate discovery and cloning of leptin, 30 years later. Coleman was very 
interested in two strains of monogenetic mutant “obese” mice that had emerged from Jackson 
Laboratory, and sought to discover the genes underlying the obese phenotype of these mutants, 
coined: db (diabetes) and ob (obesity). Using a similar approach to Hervey, Coleman performed 
parabiosis experiments and found that wild-type animals paired with db/db animals suffered 
from lethal aphagia. Furthermore, he found that ob/ob animals also became lethally anorexic 
when paired with db/dbs. This work provided the tantalizing evidence that db/db mice harbored 
excessive amounts of a yet undefined circulating satiety factor, and also that both the db and ob 
genes were involved in a common pathway (Coleman, 1973).  
Today, both the db and ob genes have been mapped and cloned, and we now know that the 
ob gene encodes the polypeptide hormone leptin, while db gene encodes the leptin receptor 
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protein (Tartaglia et al., 1995; Zhang et al., 1994). As originally hypothesized by Kennedy, it has 
been demonstrated that leptin is an adipokine produced by adipocytes in proportion to their 
triglyceride content (reviewed in: (Myers et al., 2010)). Furthermore, many cells within 
hypothalamic nuclei express a brain specific splice variant of the leptin receptor (ObRb), which 
is localized with particular density in the mediobasal hypothalamus (MBH) (Elmquist et al., 1998; 
Lee et al., 1996; Scott et al., 2009). Recombinant leptin protein administered directly into the 
brain (via intracerebroventricular (ICV) injection) of ob/ob animals largely rescued the body 
weight phenotype (Campfield et al., 1995). Based on this work, contemporary belief is that leptin 
is expressed peripherally and then relayed to hypothalamic circuits via systemic circulation, 
acting to determine food intake and energy expenditure in response to peripheral levels of 
adiposity. It is also thought that because ob/ob and db/db mutants are lacking hypothalamic 
leptin signaling, they are in a paradoxical state of starvation, and that hyperphagia in these 
animals is the consequence of a failure to detect feedback leptin signaling from the adipose. 
The Hypothalamic-Adipose Axis 
The above findings represent the foundational evidence toward defining the molecular 
details of body weight homeostasis. Research vested in furthering such efforts are of critical 
importance to contemporary society as obesity at large has reached pandemic proportions in 
the developed world and constitutes a considerable burden to the health and wellbeing of 
affected individuals (Bjorntorp, 1992; Flegal et al., 2010; Popkin). Obesity – characterized by 
excessive fat storage and indicated a body mass index of greater than 30 kg/m2 – is implicated 
in the dysregulation of many homeostatic processes that lead to the life threatening 
complications of diabetes, hypertension, and dyslipidemia. The prevalence of obesity over the 
past 40 years has increased dramatically, in trends that are not accompanied significant 
alterations in dietary conditions, and surely too rapid to be explained by evolutionary 
adaptations (Ogden et al., 2010). 
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It is well established that individuals regulate and defend threshold levels (set-points) of 
body fat, such that body weight over the course of a year is remarkably stable – a paradigm that 
holds true for both lean and obese subjects (reviewed in: (Leibel, 2008). In a weight-reduced 
state ≤ 10 percent of baseline, humans display reductions in energy expenditure and increased 
hunger (referred to as metabolic adaptation) that drives a rebound to original adiposity levels 
(Leibel and Hirsch, 1984; MacLean et al., 2004). Both obese and non-obese models exemplify 
this same metabolic paradigm; however, in the case of obesity the threshold of regulation is set 
to maintain much higher adipose levels. 
Upon cloning of leptin, the field largely anticipated its potential as a cure for human obesity. 
However, surprisingly, most obese patients have high levels of circulating leptin, and the rate of 
monogenetic mutations in either the ob or db genes are exceedingly rare (Clement et al., 1998; 
Farooqi et al., 2007; Montague et al., 1997). The majority of obesity among humans is instead 
characterized as a polygenic disorder accompanied by leptin resistance – leptin levels that are 
proportionally higher than expected when normalized to fat mass – in which recombinant leptin 
therapy is ineffective (Bluher and Mantzoros, 2009; Frederich et al., 1995). 
Hypothalamic Determinants of Body Weight: Melanocortin System  
To circumvent leptin resistance, much work has gone into determining downstream targets 
of leptin action in the brain. Exciting work towards this end has come from the identification of 
the central melanocortin (MC) system. Using a mouse model of monogenetic obesity, agouti 
viable yellow Avy, researchers have defined a class of leptin induced satiety signals which 
mediate their action through stimulation of the melanocortin receptor, MC4R. ICV injections of 
an MC4R/melanocyte agonist, MTII, acutely reduce hyperphagia in the ob/ob animals similar to 
that of leptin (Fan et al., 1997).  
Similar to Coleman’s early studies an alternative model of monogenetic obesity, Agouti 
viable yellow Avy, was used to elucidate many properties of central MC signaling. Agouti viable 
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yellow Avy/vy homozygous mutant mice are obese, have a distinctive yellow coat coloring, are 
slightly longer than controls and are prone to tumors (Wolff, 1963). Initially, the Avy mutation was 
genetically mapped to the Agouti gene locus, and found to cause aberrant, ectopic expression 
of Agouti (Bultman et al., 1992; Yen et al., 1994). Canonical agouti expression and signaling 
was first described in melanocytes of the skin, where its inhibitory action on the melanocortin 
receptor, MC1R, prevented synthesis of eumelanin, a protein responsible for black/brown 
pigmentation of hair follicles (Lu et al., 1994; Wolff, 1963). The yellow coat color phenotype of 
Avy/vy mutants was attributed to the inhibition of MC1R by AGOUTI protein, preventing binding of 
the endogenous ligand alpha-melanocyte stimulatin hormone (α-MSH) and the subsequent 
synthesis of eumelanin. Along with the elucidation of this mechanism, it was further discovered 
that melanocortin receptors had multiple isoforms and were expressed in a tissue specific 
manner. Currently, 5 MCR isoforms have been identified (MC1R-5R), two of which (-3R, -4R) 
are expressed in the brain (Gantz et al., 1993a; Gantz et al., 1993b; Mountjoy et al., 1994; 
Roselli-Rehfuss et al., 1993). 
Based on evidence presented previously, leptin signaling in the brain was believed to 
orchestrate a large part of energy homeostasis. Given this, Cone and colleagues hypothesized 
that the action of Agouti signaling on MC3R and MC4R in the brain was responsible for the body 
weight phenotype of Avy/vy animals. To test this, Cone et al. (1997) performed ICV injections of 
an α-MSH analogue, MT-II (Ac-Nle-c[Asp-His-D-phe-Arg-Trp-Lys]-NH2), and found it to induce 
satiety (Al-Obeidi et al., 1989; Chhajlani and Wikberg, 1992; Roselli-Rehfuss et al., 1993). To 
further prove that AGOUTI protein inhibited MCR signaling in the brain, Cone went on to 
develop an agouti specific mimetic called SHU9119, finding that the effects of MT-II were 
blunted by the corresponding ICV administration of SHU9119 (Fan et al., 1997). In ob/ob 
animals, ICV administration of MTII recapitulated feeding suppression similar to that found with 
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ICV leptin, suggesting that the effects of melanocortin signaling were downstream of leptin’s 
action in the brain (Campfield et al., 1995).  
These seminal findings prompted a response among the research community to further 
elucidate the properties of MC3R and MC4R, and the mechanisms by which they mediate 
satiety. Loss-of-function mutations targeted to neural MCRs can have dramatic effects on 
adiposity levels similar to those of ob/ob and db/db models. Specifically, genetic ablation of 
mc4r-/-, resulted in maturity onset obesity with noted sexual dimorphism: female adiposity 
compared to controls was approximately 50 percent more than that of males (Huszar et al., 
1997). Mc3r-/- loss-of-function mutants did not present an overt adiposity phenotype, but the 
animals were more prone to obesity when challenged on a high fat diet and were shorter in 
length compared to controls (Chen et al., 2000). Altogether, this work supported that the 
influence of central MC signaling on body weight determination was predominantly mediated by 
MC4R, while MC3R appeared to play a minor role. 
Generally, MC3R and 4R are thought to localize to mutually exclusive neuronal populations. 
Transgenic mc4r reporter analysis indicated the presence of MC4R in both neurons and 
astrocytes of the: cortex, thalamus, hypothalamus, parabrachial (PB), brainstem, spinal cord 
and hippocampus; with notable density in the paraventricular nucleus of the hypothalamus 
(PVH) and also in the dorsal motor nucleus of the vagus nerve (DMX) in the brainstem (Gantz et 
al., 1993b; Liu et al., 2003). In the brain, mc3r expression was more limited, identified mainly in 
the arcuate nucleus of the hypothalamus (ARH) with low levels of expression detected in the 
thalamus and brainstem. Mc3r expression was also identified in some peripheral tissues 
including: placenta, heart, kidney, stomach, adipose tissue, skeletal muscle, duodenum, and 
pancreas (Chhajlani, 1996; Gantz et al., 1993a).  
To further understand the physiologic role of central MC signaling in energy homeostasis, 
researchers went on to define the endogenous ligands of the system. As discussed previously, 
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the endogenous melanocyte agonist, α-MSH was known to mediate MC1R dependent hair 
follicle pigmentation. α-MSH is a cleavage product of the pro-peptide POMC. Post-translation 
modifications of the pro-peptide, POMC, has been demonstrated to occur in a tissue specific 
manner, resulting in a multitude of functional POMC derived peptides. In the hypothalamus 
processing of POMC occurs according to the diagram below (depicted in a recent review by Dr. 
Sharon Wardlaw, Figure 1.1 (Wardlaw, 2011)). The processing enzymes pro-hormone 
convertase (PC) isoforms PC1/3 and PC2 are expressed in the hypothalamus along with 
carboxypeptidase E (CPE). Upon translation, POMC is targeted and trafficked to the golgi 
where the functional products are then processed and packaged into secretory granules. POMC 
is initially cleaved into two main functional derivatives; adrenocorticotropic hormone (ACTH) and 
beta-lipotropin (β-LPH). In the hypothalamus these products are further processed by the action 
of PC2 and CPE which converts ACTH into an amidated form of deacetyl-α-MSH (1-13) and 
CLIP, while β-LPH is further processed into β-endorphin (β-EP) and β-MSH (Emeson and 
Eipper, 1986). In the mature brain Pomc is expressed throughout the medialbasal hypothalamus 
in regions of the retrochiasmatic area, ARH and mammillary nucleus (Knigge et al., 1981). 
Extra-hypothalamic sites of Pomc expression in the mature brain include the retina, spinal cord, 
commissural nucleus of the solitary tract (cNTS) and area postrema (AP) (Bronstein et al., 1992; 
Gallagher et al., 2010; Lein et al., 2007; Watson et al., 1978). To date POMC derived MSH 





Targeted genetic ablation of the Pomc gene resulted in a phenotype that trended toward 
mc4r-/-null characteristics, including maturity onset obesity and an increase in body length 
(Yaswen et al., 1999). However, the phenotype of these two models differed in final body 
weight; adult Pomc-/- nulls weighed ~20 percent less than mc4r-/-nulls. One explanation for this 
discrepancy: unlike Mc4r-expressing cells, Pomc-expressing cells are not restricted to the brain 
and in particular are present in corticotrophs of the anterior pituitary. To resolve this issue, Low 
et al. (2006) generated animals in which pituitary Pomc expression was rescued on a Pomc-/- 
background. Surprisingly, the obesity phenotype of these Pomc-/-tg+ animals was exacerbated, 
achieving adiposity levels comparable to that of the mc4r-/- (Smart et al., 2006). Importantly, 
POMC in the pituitary is processed to Adrenocorticotropic Hormone (ACTH) and communicated 
Fig. 1.1. “POMC processing. Schematic diagram of the POMC precursor molecule and the 
major peptide products that are derived from this precursor by endoproteolytic cleavage. JP 
= Joining peptide; LPH = Lipotropin; EP = Endorphin; CLIP = Corticotropin-like-intermediate 
lobe peptide; da-α-MSH = desacetyl α-MSH; PC1/3 and PC2 = Prohormone convertases 1/3 
and 2; CPE = Carboxypeptidase E; N-AT = N-acetyltransferase; PAM = Peptidyl α-amidating 




to the adrenal gland via the pituitary/adrenal axis. In the adrenal, ACTH stimulates the release 
of corticosterone, a peripherally circulating orexigen. Hence, Pomc-/-tg+ animals weigh more 
than global Pomc-/- nulls due to corticosterone signaling in the periphery.  
Further work identified an endogenously expressed Agouti isoform in the brain.  Agouti-
related protein (AgRP) expression was identified in neurons of the medial aspect the ARH and 
also in the adrenal gland (Broberger et al., 1998). Using an in-vitro culture system, Barsh et al. 
(1997) used kinetic binding assays to investigate AgRPs action on distinct MCR isoforms. 
These studies showed that AgRP specifically prevented α-MSH-induced cAMP in both MC3R 
and MC4R isoforms, but did not disrupt this activity in other MCR variants (Ollmann et al., 
1997). In this same study the Barsh lab also generated an in vivo model of AgRP 
overexpression, by engineering an Agrp transgene under the control of the β-actin promoter, 
Tg-Agrp. This gain-of-function model resulted in animals that were obese and longer in naso-
anal length compared to controls. Compared to mc4r-/-, Tg-Agrp overexpression achieved ~70 
percent of the body weight phenotype (Ollmann et al., 1997).  
Similar to central leptin signaling, MC circuits in the brain can dramatically influence body 
weight homeostasis.  Because ICV injections of the melanocyte agonist MTII, had similar effects 
to ICV leptin in ob/ob animals, it was anticipated that targeting this downstream circuit would 
bypass leptin resistance in many common forms of obesity. Diet induced obese (DIO) animals 
have a form of heritable susceptibility to obesity which is induced by a Western-type diet (Levin 
et al., 1997). In these animals, leptin levels are high in proportion to fat mass, however they are 
resistant to its effects in the brain. Unfortunately, administration of pharmacologic MTII into the 
brains of DIO animals had marginal effects body weight and adiposity, indicating that central 
leptin resistance may lie at the level of MC circuits (Banno et al., 2007). A search for an effective 
pharmacologic treatment for obesity remains elusive. 
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Hypothalamic Determinants of Body Weight: NPY/AgRP 
Prior to the discovery of AgRP (1998), an alternative neuropeptide circuit, stimulated by the 
endogenous ligand neuropeptide Y (NPY), was determined to elicit orexigenic effects. NPY is 
the most abundant neuropeptide in the brain and numerous physiologic functions are attributed 
to NPY signaling including: food intake, blood pressure and circadian rhythms (Allen et al., 
1983; Balasubramaniam, 1997). NPY is a member of homologous proteins including: pancreatic 
polypeptide and polypeptide YY, peptide YY and seminalplasmin, all characterized by a 36 
amino acid sequence and a structural signature that includes a hairpin-like loop referred to has 
a PP-fold (Fuhlendorff et al., 1990; Tatemoto, 1982; Tatemoto et al., 1982). Central ICV 
injections of NPY stimulate consummatory behavior; injected animals eat more frequently and 
overall consume more calories (Clark et al., 1984; Levine and Morley, 1984).  
The orexigenic effects of NPY are predominantly determined by the ligands interaction with 
NPY receptor-expressing neurons in the paraventricular nucleus of the hypothalamus (PVH). 
Compared to ICV injections, direct injections of NPY into the PVH induced a fourfold greater 
effect on stimulated caloric intake (Stanley and Leibowitz, 1985). Diurnal analyses of NPY 
protein concentration in the PVH revealed that levels of NPY released into the PVH change 
dynamically in relation to prandial state. Levels of NPY in the PVH were highest in the fasted 
state and lowest postprandial (Kalra et al., 1991). Together, these data support that NPY is 
released into the PVH in response to fluctuating feeding patterns and that the action of NPY in 
the PVH can stimulate feeding. 
In the 80s it was assumed that alpha-adrenergic receptors in the PVH were mediating the 
effects of NPY via the autonomic nervous system. However, administration of phentolamine, an 
alpha-adrenergic receptor antagonist, prior to direct NPY injections did not attenuate stimulated 
food intake (Stanley and Leibowitz, 1985). Since these studies, five NPY receptor isoforms, 
NPYR 1-5 (YR1-YR5), have been defined. YRs are stereotypical class A, G protein coupled, 
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rhodopsin-like receptors, which exclusively bind NPY family ligands. In vitro kinetic studies have 
shown that, of NPY family proteins, NPY has the most affinity for YR1, YR2 and YR5. 
Pharmacologic agonist and antagonists against these receptor subtypes have shown that NPY 
mediates its effects on orexigenic behavior predominantly through YR5 receptors (Gerald et al., 
1996). YR5 is expressed in many areas of the brain, including a dense population of cells in the 
hippocampus and cortex with moderate expression levels in the thalamus, amygdala, dorsal 
raphe and the hypothalamus (including the PVH, LHA, SON and ARH) (Gerald et al., 1996). 
In 1998, numerous studies determined that Npy transcript was co-localized with Agrp, 
indicating that ≥ 95 percent of NPY neurons in the ARH were AgRP+ (Hahn et al., 1998; Shutter 
et al., 1997). Because Agrp expression is restricted to the ARH (Broberger et al., 1998), it can 
be used to distinguish NPY/AgRP neurons in the ARH from ‘other’ NPY+ neurons in alternative 
regions of the CNS.  
Given these findings, a series of in vivo loss-of-function genetic mutants were engineered to 
further understand the physiology of the NPY/AgRP system. Initially, the Palmiter laboratory 
generated a genetically null Npy-/- mouse model, and surprisingly found that Npy-/- mice did not 
exhibit a body weight phenotype and responded normally when fast challenged (Erickson et al., 
1996). Furthermore, genetically null Agrp-/- mutants, along with double null Npy-/-/Agrp-/-, did not 
present a phenotype related to energy homeostasis (Qian et al., 2002). Next, based on the 
pharmacologic data implicating Y5Rs in NPY stimulated food intake, Palmiter et al. (1998) 
generated a genetically null Y5R mouse model. As with the NPY null animals these mice did not 
have an overt body weight phenotype (Marsh et al., 1998). Despite considerable evidence that 
NPY, AgRP and Y5R play a central role in stimulating appetite, genetic ablation of these genes 
had little impact on energy homeostasis outcomes. At the time, Palmiter hypothesized that 
these genetic manipulations altered the developmental establishment of the hypothalamus 
leading to compensatory modifications. To avoid these potential confounds, the Palmiter group 
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(2005), along with others, went on to ablate NPY/AgRP neurons in a temporally controlled 
manner (Gropp et al., 2005; Luquet et al., 2005). Specifically, Palmiter et al (2005) generated 
transgenic animals in which the regulatory elements of Agrp were used to drive expression of a 
diphtheria toxin receptor (DTR) transgene, AgRP:dtr+/+. Upon administration of diphtheria (DT), 
Agrp expressing cells were targeted for complete cellular ablation. These studies revealed that 
ablation of AgRP neurons in the mature brain results in lethal anorexia; the mice became 
aphagic and rapidly died of starvation (Luquet et al., 2005). Interestingly, if DT was administered 
early, during the perinatal period, the animals survived, had a lean phenotype and were 
resistant to diet-induced obesity.  
To narrow down some of the compensatory signals Palmiter and colleagues crossed 
AgRP:dtr+/+ transgenics to genetically null Npy-/-/Agrp-/- animals. Administration of DT to these 
animals surprisingly induced acute lethal anorexia. The compensation found in double null Npy-/-
/Agrp-/- mutants was diminished by later ablation of these cell bodies, consistent with the idea 
that a potent compensatory orexigenic signal resided in AgRP neurons (Phillips and Palmiter, 
2008). Because AgRP was thought to largely act through antagonism of MC3 and 4R, Palmiter 
et al. (2008) next crossed AgRP:dtr+/+ transgenics to the agouti viable yellow strain, Avy/vy and 
found that administration of DT in mature animals also induced lethal anorexia (Wu et al., 2008). 
Because ectopic AGOUTI, of the Avy/vy mutant strain should inhibit MCRs, it was surprising that 
such a manipulation, in the absence on anorexigenic melanocortin signaling, induced 
hypophagia. This model is consistent with the idea that central melanocortin circuits are not 
paramount to the anorexigenic response.  
At the time it was known that gamma-aminobutyric acid (GABA) receptor agonists 
stimulated feeding (Cooper and Higgs, 2005; Ebenezer and Surujbally, 2007), and also that 
NPY/AgRP neurons co-expressed GABA (Cowley et al., 2001; Horvath et al., 1997). To test 
whether the neurotransmitter, GABA, was the elusive compensatory orexigenic signal, Palmiter 
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et al. (2009) infused a GABA agonist via subcutaneous minipump to AgRP:dtr+/+ mutants, 
finding it sufficient to rescue the lethal anorexia phenotype upon DT administration. The lab 
went on to define the PB as the critical secondary target, which, in the absence of GABA 
inhibition, elicits potent anorexigenic affects (Wu et al., 2009). It should be noted that genetic 
inactivation of GABA signaling in AgRP neurons – achieved by conditional inactivation of the 
vesicular GABA transporter gene (Vgat), AgRP:Vgatfl/fl – phenotypically resembled the mild 
phenotype observed after ablation of AgRP in neonatal mice. AgRP:Vgatfl/fl were lean and 
resistant to diet-induced obesity, suggesting that, as with AgRP ablation, compensation can 
occur when GABA production in AgRP neurons is compromised during early development 
(Tong et al., 2008). All together, these studies suggest that plasticity during development can 
overcome early insults to central feeding circuits, and are particularly adept to compensate for 
orexigenic signals which assure the health and survival of the organism.  
In the recent literature many labs have designed inducible genetic reagents, which can be 
activated in the mature system, avoiding developmental compensation. For example the Lowell 
laboratory has engineered designer receptors exclusively activated by designer drugs 
(DREADD) technology into AgRP neurons, AGRP:Dreadd+/+, to provide specific and reversible 
regulation of neuronal activity. In the mature state, a DREADD agonist was administered, 
inducing AgRP-specific depolarization, and induced an acute stimulation of food intake (3-fold 
induction following a single injection) and decreased energy expenditure (1.3-fold). Upon 
multiple dosages of the DREADD agonist, the mice gained a substantial amount of weight in the 
form of adiposity, which was acutely reversed upon withdrawal of treatment (Krashes et al., 
2011). Similarly, investigators of the Sternson laboratory have engineered a channelrhodopsin-2 
channel into AgPR neurons; AgRP:Chr2+/+, to provide a means for conditional photostimulation. 
In the mature state, light was used to selectively stimulate AgRP-specific depolarization, and 
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similar to the DREADD agonist, induced an acute stimulation of food intake, which diminished 
upon decreasing stimulus frequency (Aponte et al., 2011).    
POMC and NPY Neurons: Response to the Environment  
The current dogma of energy homeostasis is that autonomic and neuroendocrine effects on 
feeding behavior and energy expenditure are primarily elicited by the anorexigenic POMC and 
orexigenic AgRP neurons in the ARH. Electrophysiological recording studies have shown that 
POMC and AgRP neuronal activity is influenced by peripheral energy status 
namely: leptin, insulin and glucose (reviewed in: (Morton et al., 2006)). Because the ARH is 
positioned adjacent to the median eminence, a uniquely fenestrated area of the blood brain 
barrier, it is believed that these signals in the peripheral circulation are transmitted into the 
internal milieu of the ARH to regulate food intake and energy expenditure. 
Leptin: Leptin-sensing in proportion to adiposity stores and has been shown to play a 
critical role in hypothalamic determination of food intake. Via modulation of the downstream 
transcription factor STAT3, leptin transduction induces expression of Pomc while inhibiting that 
of Agrp (Kitamura et al., 2006; Korner et al., 2001; Morrison et al., 2005). Consistent with this, 
electrophysiological recordings indicate that leptin depolarizes a subset of POMC neurons, 
while conversely hyperpolorizing NPY/AgRP neurons (Claret et al., 2007; Cowley et al., 2001; 
Plum et al., 2006; Williams et al., 2010). Given this, it was anticipated that in vivo loss-of-
function leptin receptor mutations (Leprfl/fl) targeted to POMC and AgRP neurons would induce 
an obesity phenotype comparable to that of global leptin mutants (approximately 2.6-fold 
increase). Surprisingly, targeted genetic ablation of Leprfl/fl using conditional Agrp-Cre and 
Pomc-Cre had a marginal effect compared to the global leptin mutants. POMC:Leprfl/fl animals 
were relatively eumetabolic, with a body weight phenotype accounting for a modest 15 percent 
of that incurred in global leptin mutants (Balthasar et al., 2004). AgRP: Leprfl/fl mutants likewise 
presented a mild obesity phenotype attributed to transient hyperphagia and reduced energy 
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expenditure in young male mice (van de Wall et al., 2008). AGRP+POMC:Leprfl/fl double knock-
outs were expected to exacerbate the body weight phenotype, but instead presented marginal 
increases in body weight, accruing only 18 percent of the body weight phenotype of global 
mutants, along with decreased core temperature and locomotor activity. 
Insulin: Insulin, a hormone released in response to elevated blood glucose levels, circulates 
as an indicator of peripheral glucose supply. Like leptin, insulin has been shown to influence 
central circuits involved in feeding behavior and energy expenditure, albeit with much lesser 
effects. Neuronal specific ablation of the insulin receptor (Irfl/fl) using the Nestin-Cre driver 
(NIRKO) resulted in mild, sex-specific phenotypes including: insulin resistance, body weight and 
adiposity (achieving roughly 20 percent of global leptin mutants) (Bruning et al., 2000). Via 
modulation of the downstream transcription factor FOXO1, insulin transduction acts  to activate 
Pomc transcription while inhibiting Agrp (Belgardt et al., 2008; Kitamura et al., 2006). 
Furthermore, ICV administration of insulin up-regulates Pomc and down-regulates Npy 
expression levels (Schwartz et al., 1992; Sipols et al., 1995). While the transcriptional influence 
of insulin on Pomc and Agrp corresponds with that of leptin, electrophysiological recordings 
yield a paradoxical response. Insulin inhibits a subset a subset of POMC neurons while 
activating AgRP neurons (Claret et al., 2007; Konner et al., 2007; Plum et al., 2006; Williams et 
al., 2010). Because NIRKO mice did not yield a striking phenotype, in vivo loss-of-function 
studies targeting AgRP and POMC neurons were not anticipated to yield dramatic body weight 
phenotypes. Both AgRP:Irfl/fl and POMC:Irfl/fl present normal body weight and energy 
homeostasis, even when challenged on a high fat diet (Konner et al., 2007; Lin et al., 2010).  
Glucose: Glucose is an essential fuel for cells in the CNS, but can also act as a signaling 
molecule influencing membrane potential in disparate “glucose-sensing” neurons. It is estimated 
that 10 to 30 percent of neurons in the hypothalamus are glucose-sensing, characterized by the 
action and expression of two gating intermediates – 5' adenosine monophosphate-activated 
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protein kinase alpha 2 (AMPKα2) and an ATP-activated potassium channel (KATP) – which 
influence membrane potential in response to glucose (Levin et al., 2004; Minokoshi et al., 2004). 
Measured by electrophysiological recording a subset of POMC neurons (approximately 50 
percent) are glucose-excited, while AgRP neurons can exhibit either glucose stimulated 
depolarization or hyperpolarization in mutually exclusive subsets (Claret et al., 2007; Fioramonti 
et al., 2007; Ibrahim et al., 2003; Murphy et al., 2009; Parton et al., 2007). It has been argued 
that the concentration of glucose in the internal milieu of the brain is much less than that found 
in the blood, calling to question the physiological relevance of the doses of glucose used in 
many of the afore mentioned recording studies (de Vries et al., 2003; Routh, 2002). In the 
literature in vivo loss-of-function studies find inconsistent results with respect to the glucose-
sensing hypothalamic response. AgRP:ampkα2fl/fl are eumetabolic with respect to glucose 
homeostasis, metabolic rate, feeding behavior, physical activity and percent adiposity, but 
present a mild lean mass phenotype (Claret et al., 2007). POMC: ampkα2fl/fl demonstrate 
significantly increased in food intake, body weight and percent adiposity, accompanied by a 
decrease in resting metabolic rate and brown adipose tissue UCP1 (Claret et al., 2007). On the 
other hand, POMC:KATP-/- mutants do not exhibit alterations relative to body weight, adiposity or 
metabolic rate, but instead exhibit increased glucose excursion upon glucose tolerance testing 
(Parton et al., 2007). In summary, the parameters used to study glucose-sensing neurons have 
been either out of the physiologic range or did not yield consistent in vivo results, leading the 
field to largely dismiss the relevance of glucose-sensing neurons in the hypothalamus (reviewed 
in: (Levin, 2007)).  
To date, conditionally targeted in vivo functional manipulations using Argp-Cre or Pomc-Cre 
driver lines have produced mild phenotypes with respect to energy homeostasis. It is clear from 
electrophysiological recordings that discrete subpopulations of POMC and AgRP neurons 
respond uniquely to leptin, insulin and glucose, thus targeting the entire heterogenous 
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population may result in confounding outcomes. In the future, the elucidation of genetic 
reagents for distinct POMC and AgRP homogenous subpopulations will be paramount to 
defining the physiologic relevance of these subsets. Also, as illustrated by genetic knock-out 
models of Npy-/- and Agrp-/-, the developing brain is highly plastic, and early genetic 
manipulations can influence the function of germ cells leading to compensatory alterations. It is 
important to keep in mind that the onset of both Agrp-Cre (postnatal day 9) and Pomc-Cre 
(embryonic day 10.5) expression occur during development when cells of the mediobasal are 
undergoing differentiation. It is possible that targeted genetic manipulations using these drivers 
may induce compensatory changes in the developing system, resulting in diminished outcomes.  
Development of the ARH 
To better understand plasticity, it is important to understand the ontogeny of cells in the 
ARH. The presumptive ARH derives from the ventral diencephalon (an aspect of the developing 
forebrain that gives rise to the thalamus and hypothalamus). Naïve progenitor cells in this region 
of anterior neuroectoderm are steered toward a ventral forebrain fate by the influence of WNT 
and NODAL signals that diffuse from the axial mesoderm during gastrulation (reviewed in: 
(Wilson and Houart, 2004)). In subsequent stages of development, sonic hedgehog (SHH) plays 
a role in defining ventral cell identity along the rostral-caudal extent of the neural tube (Ericson 
et al., 1995). Recent reports find that the SHH derived from ventral forebrain neuroepithelium is 
the primary inducer in of cell fates of the anterior and tuberal hypothalamus, including the ARH 
(Shimogori et al., 2010). Exogenous hedgehog signaling in the hypothalamus induces the 
expression of the transcription factor NKX2.1 – activated as early as embryonic day 8 in the 
mouse – a principle intrinsic factor common to most cells of the ventral subpallium and 
hypothalamus (Price et al., 1992; Shimamura and Rubenstein, 1997; Sussel et al., 1999). 
Transcription factors direct genetic programs involved in the specification of distinct cell 
identities. NKX2.1 is a member of mammalian NKX family of homeobox-containing genes, found 
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(among other regions) in the proliferative zone of the hypothalamus, including the presumptive 
ARH (Shimamura et al., 1995). Lineage tracing studies have shown that most cells of the 
mature ARH derive from Nkx2.1-expressing precursors (Ring and Zeltser; Xu et al., 2008). More 
specifically, most ARH cells destined toward a neuronal fate are derived from Mash1-expressing 
progenitors. MASH1 is a pro-neural transcription factor that promotes neurogenesis via 
activation of the Neurogenin (NGN) transcription factor family (Horton et al., 1999). Both MASH1 
and NGN family transcription factors contain stereotypic basic helix-loop-helix (bHLH) 
structures. In the developing hypothalamus, MASH1 activation of NGN2 is thought to determine 
the neurogenic potential of both the ARH and VMH (Parras et al., 2002). Mash1-/- null mice 
display an underdeveloped ventral hypothalamus including a loss of neuroendocrine type cell 
types in the ARH and VMH (McNay et al., 2006).  
Birthdating studies have shown that the majority of neurons in the ARH are born – exit 
mitotic division – between E11.5 and E12.5 in the developing mouse (Altman and Bayer, 1978; 
Padilla et al., 2010). Of the entire population of cells in the ARH, POMC and NPY/AgRP 
neurons comprise only a minority, with others including: tyrosine hydroxylase (TH), growth 
hormone related hormone (GHRH), gonadotropin-releasing hormone (GnRH), somatostatin 
(SS), kisspeptin (KISS), galenin (GAL) and pro-dynorphin (pDNY). The function of neurons that 
reside in the ARH is not limited to energy homeostasis, but also includes outputs involving: 
somatic growth, reproduction, sexual behavior and analgesics. While the specific programs 
involved in the differentiation of POMC and AgRP terminal fates are unknown, recent data 
investigating the role of NGN3 provides some clues as to the differentiation of the Pomc lineage. 
In an Ngn3-/- mouse model, Ang et al. (2010) find a diminished number of POMC neurons 
accompanied by a counterbalance expansion of both NPY and TH+ cells in the MBH (Pelling et 
al., 2010). This data supports that Ngn3 is involved in the specification of a lineage including 
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NPY, TH and POMC terminal fates, and provides rudimentary evidence toward understanding 
the patterning of neurons in the ARH. 
Programming of Body Weight Outcomes 
During development, pluripotent progenitor cells differentiate to acquire a terminal cell fate, 
precise projection pattern and appropriate physical location. In the murine model, the timing of 
terminal cell fate decisions occurs during embryogenesis, while axonal extension occurs during 
the perinatal period (Altman and Bayer, 1978; Bouret et al., 2004; Padilla et al., 2010). During 
such processes of cellular definition, the developing organism is highly plastic and vulnerable to 
alterations. For example, experiments performed in the 1960’s demonstrated that male sex 
steroids administered to female animals during development could permanently impact the 
female reproductive axis. Specifically, Gorski and Barraclough (1963) found that a single bolus 
injection of testosterone administered 5 days after birth (P5) was sufficient to permanently stunt 
the reproductive outcome in females. Exposed females became sterile and lacked an estrus 
cycle in later life (Gorski and Barraclough, 1963). Alternatively, in classical studies of ocular 
dominance, Hubel and Wiesel (1963) first demonstrated that retinal exposure to the specific 
sensory input of light and patterns are critical to proper development of neural projections that 
determine visual sensations.  In seminal studies, they sewed the eye of a cat shut and found 
that if deprived of patterned visual inputs during a critical period of perinatal development, the 
animal experienced a permanent loss of cortical responsiveness in the manipulated eye (Wiesel 
and Hubel, 1963).  
Findings of this sort, led David Barker to hypothesize that the maternal nutrient and 
hormonal environment can impart lasting effects on the developing offspring. He argued that 
because exposure to environmental toxins during specific susceptible periods of development – 
for example testosterone exposure at P5 or the absence of visual input perinatally – can bias 
the establishment of the future reproductive axis and visual axis, then it was possible that 
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maternal nutrient and hormonal environment could impart lasting effects of the developing 
offspring. These ideas lead to a new field of research vested in defining the fetal-origins of adult 
disease.  
Today, a large body of epidemiologic data in humans and studies of animal models supports 
that maternal nutrition during gestation can impart permanent changes on the metabolic 
outcome of the developing fetus. Studies of both over- and under-nutrition during gestation have 
shown an increased risk for the offspring to develop obesity in adulthood (reviewed in: (Grattan, 
2008)). Along with this, long-term prospective, longitudinal clinical studies investigating the 
effects of gestational diabetes have found that a diabetic intrauterine environment increased the 
relative risk for the offspring to develop obesity and Type 2 diabetes (Dabelea et al., 2000; 
Silverman et al., 1998). Furthermore, retrospective data following humans after bariatric surgery 
induced weight loss have found that siblings gestated in a lean maternal environment were ~50 
percent less likely to become obese than those of an obese maternal environment (Kral et al., 
2006). Together, this data supports Barker’s hypothesis that the intrauterine nutrient and 
hormonal environment has effects on offspring that extend well beyond the neonatal period, and 
can program metabolic outcomes in developing offspring.  
To date, little is known regarding the mechanisms underlying maternal programing of 
metabolic outcomes, however a growing body of evidence supports that feeding related signals 
generated in the hypothalamus can be programmed and may play a role in body weight 
outcomes in offspring. Since the early 1990s Plagemann et al. have established numerous 
models of gestational over- and under-nutrition to study the detailed effects of the gestational 
environment in exposed offspring. In this work they have provided seminal data to suggest 
hypothalamic nuclei and feeding related signals are compromised in obesity-prone offspring 
from these models (reviewed in: (Plagemann, 2005)). Towards this same end, others have 
found that base-line levels of hypothalamic signals that regulate food intake and energy 
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expenditure, including Npy/Agrp and Pomc transcripts, are altered in obesity-prone/gestationally 
exposed offspring (Chen et al., 2008; Leibowitz et al., 2007). Together, these findings correlate 
alterations of energy-related signals from the ARH in response to the maternal nutrient and 
hormonal environment. To further investigate this effect at the single cell level, Simerly et al. 
(2008) have investigated the outcome of neurons in the hypothalamus using a model of 
maternal obesity previously established to impart a propensity toward obesity in exposed 
offspring. In this model, they found approximately 24 percent fewer leptin-responsive neurons 
(PSTAT3 +) in the ARH of exposed animals, suggesting that the gestational nutrient and 
hormonal can influence the establishment of functional populations in the ARH (Bouret et al., 
2008). In studies unrelated to energy expenditure, Spitzer et al. (2008) have found that cell-type 
neurotransmitter identity in motorneurons can be biased by acute exposure to excitatory, 
glutamate or inhibitory GABA signals during sensitive periods of differentiation (Root et al., 
2008). Based on this evidence we hypothesize that exogenous nutrient and hormonal factors 
during gestation can act on differentiating neurons in the hypothalamus during sensitive periods 
of development to bias the cell-type identities of these neurons. For example, the obese 
microenvironment includes elevated circulating levels of: insulin, leptin, triglyceride and cortisol, 
all of which may serve as exogenous signals influencing cell fate decisions in the ARH, 
potentially resulting in Simerly et al’s finding of reduced leptin-sensing neurons in exposed 
offspring. In conclusion, these studies raise the possibility that developmental events can 
influence cell fate decisions in the developing hypothalamus, and provide a target to further 
investigate epidemiologic data that maternal obesity confers risk for obesity in offspring. 
Hypothalamic Projections Related to Feeding 
The ontogeny of neurite outgrowth from the ARH has been mapped. Using Di-I crystal 
labeling, Simerly et al. (2004) find that the majority axonal extension from the ARH occurs 
during the second week of postnatal development reaching mature projection patterns by 
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postnatal day 18 (P18) (Bouret et al., 2004). Mature projection patterns from the ARH largely 
terminate within the hypothalamus with a minority of projections terminating in other regions of 
the brain. Inter-hypothalamic targets from the ARH include: the PVH, preoptic area (POA), 
anteroventral periventricular nucleus (AVPV), dorsal medial hypothalamic nucleus (DMH), 
ventral medial hypothalamic nucleus (VMH), lateral hypothalamic area (LHA) and interneurons 
within the ARH (Bouret et al., 2004; Cowley et al., 2001). Extra-hypothalamic targets from the 
ARH include: the AP, bed nucleus of the stria terminalis (BNST), DMX, intermediolateral cell 
column (IML), lateral septal nucleus (LS), median eminence (ME), nucleus of the solitary tract 
(NTS), PB and periaqueductal gray (PAG) (Broberger et al., 1998; Elias et al., 1998a; Risold et 
al., 1997; Shin et al., 2008; Wu et al., 2009; Zhang et al., 2011). The ARH is not the only 
nucleus within the hypothalamus that mediates energy homeostasis, others include: the PVH, 
DMH, VMH, LHA, POA and suprachiasmatic nucleus (SCH), hereafter referred to as the 
“feeding centers” (Morton et al., 2006). Aside from mediating bodyweight, overall hypothalamic 
function is attributed to: hydration, growth, reproduction, thermoregulation, circadian rhythm, 
defense, arousal, motivated behavior and the onset of puberty (Swanson, 2000). In an 
evolutionary sense, the fitness of an organism depends on ample energy supply and therefore 
the efficiency of energy homeostasis to meet cellular work demands will establish the baseline 
for the ancillary hypothalamic functions listed above. For example, reproduction and somatic 
growth require positive energy balance; these processes are blunted in starving organisms 
(Rosenbaum and Leibel, 1999). As mentioned earlier, because ob/ob and db/db animals lack 
leptin signaling, they represent an insatiably starved system, and are also infertile. 
Hypothalamic body weight regulation is ultimately determined by efferent signaling circuits 
which originate in the feeding centers and terminate in areas of the brain responsible for 
mediating all aspects of motor output, including: visceromotor, secretomotor and somatomotor 
(Fig 1.1). For example, circuits traced from the ARH, VMH, PVH and DMH terminate in the IML 
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(Elias et al., 1998a; Risold et al., 1997; Zhang et al., 2011). The IML is the primary autonomic 
nervous system hub, sending signals to sympathetic ganglia which induce visceromotor 
function; and in this case, influence autonomic basal metabolic rate via sympathetic nervous 
system (SNS) tone (Saper, 2002). In addition, some neurons in the ARH and PVH terminate in 
the median eminence, at the base of the hypothalamic-pituitary portal. Central signals released 
in the hypothalamic-pituitary portal are then communicated to the pituitary, defining 
neuroendocrine secretomotor output, which among other things can directly influence caloric 
intake and energy expenditure. Finally, non-homeostatic, cognitive and hedonic aspects of 
feeding behavior are determined by somatomotor output from the hypothalamus to regions of 
the midbrain including the PAG, PB and ventral tegmental area (VTA). Retrograde labeling from 
these areas has identified sources of efferent input in the ARH and LHA (Harris et al., 2005). 
Sensory, cortical and behavioral afferent projections, along with endogenous hormones that 
influence the “feeding centers,” act in concert to determine body weight in response to the 
energy supply and work demand. The PVH receives input from the hippocampus, medial 
amygdala, subiculum, ARH, DMH, pre-optic area (POA) and NTS. The VMH receives input from 
the ILA, BNST and ARH. The DMH receives input from the ARH and POA. The ARH receives 
input from POA, VMN, SCH and NTS. The LHA receives input from the ARH (Bouret et al., 
2004; Elias et al., 1998b; Sternson et al., 2005; Swanson, 2000; Swanson and Kuypers, 1980; 
Zhang et al., 2011). Along with the influence of signals from these afferent circuits, the “feeding 
centers” are also influenced by endogenous signals in peripheral circulation; such afferents 
include: the pancreatic hormone insulin, and the adipose derived adipokine leptin, along with 
meal related signals from the gut: PYY, GLP-1, CCK and ghrelin, act on primary hypothalamic 
neurons to influence energy homeostasis, reproduction and somatic growth (Flier, 2004).  
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The diagram below illustrates the central circuits involved in mediating body weight [please 
note, this diagram does NOT represent all hypothalamic circuits, but includes what is known 
about those relevant to energy homeostasis] (Figure 1.1). 
 
Projection patterns of neurons of POMC and AgRP neurons have also been characterized. 
Many AgRP+ fibers terminate locally within the hypothalamus, in aspects of the PVH, VMH, 
DMH and inter-ARH. Some AgRP fibers project outside of the hypothalamus terminating  in the 
lateral septal nucleus, bed nucleus of the stria terminalis, periaqueductal gray, parabrachial, AP, 
NTS, DMX and IML (Broberger et al., 1998; Shin et al., 2008; Wu et al., 2009). Considering that 
AgRP acts in an inhibitory fashion to MC signaling, most AgRP and αMSH+ fibers terminate in 
similar regions of the brain (Elmquist et al., 1998; Elmquist et al., 1999; Zheng et al., 2010). 
Concluding Remarks 
Obesity is implicated in the dysregulation of many homeostatic processes that lead to the 
life threatening complications of diabetes, hypertension, and dyslipidemia (Bjorntorp, 1992). 
Fig. 1.2 Hypothalamic circuits involved in body weight homeostasis, depicted in a hemi-
horizontal plane from the ventral surface. Arrows denote axonal projections: green, inter-
hypothalamic; red, hypothalamic input; blue, hypothalamic output; black, extra-
hypothalamic relays. (literature summary: (Bouret et al., 2004; Broberger et al., 1998; Elias 
et al., 1998b; Shin et al., 2008; Sternson et al., 2005; Swanson, 2000; Swanson and 




Despite concerted efforts toward dietary intervention, the prevalence of obesity over the past 40 
years has increased dramatically (Leibel et al., 1995; Ogden et al., 2010). A large body of 
epidemiologic data in humans and studies of animal models supports that maternal nutrition 
during gestation can impart permanent changes on the metabolic outcome of the developing 
fetus, and (among other things) can program a propensity for obesity in offspring, such that 
exposure to a high-fat diet can induce permanent body weight increases. It is possible that 
susceptibility of obesity is instilled during gestational development, and considering high-fat 
diets are available at little to no energetic cost in the developed world, may explain the rapid 
emergence of this disorder in these societies. Relatively little is known regarding the molecular 
determinants of maternally programmed obesity susceptibility; however some early findings 
indicate that hypothalamic output and composition are altered in maternally programmed, 
obesity-prone offspring. In the following studies we will begin to establish the ontogeny of 
energy-related signals in the hypothalamus. If these events are susceptible to environmental 
insult during gestation, then it is possible that targeted intervention of early hypothalamic 
differentiation decisions may prove an effective target towards combating obesity. 
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CHAPTER 2 “Pomc-expressing Progenitors Give Rise to Antagonistic Neuronal 
Populations in Hypothalamic Feeding Circuits.”  
Introduction  
It is well established that the maternal environment can program body weight phenotypes in 
offspring, yet little is known regarding the underlying mechanism of this programmed effect 
(reviewed in (Levin, 2006)). Recent findings suggest that the establishment of leptin-sensing 
neurons in the hypothalamus may be vulnerable to an obese gestational environment. 
Specifically, Simerly and Bouret et al. (2008) have shown that obesity prone offspring reared in 
an obese gestational environment have fewer leptin-sensing neurons (~20% fewer P-STAT3 
positive cells upon acute fasted leptin injection) in the arcuate nucleus of the hypothalamus 
(ARH) compared to controls (Bouret et al., 2008). This work suggests that alterations in the 
differentiation and specification leptin-sensing neurons in the ARH may underlie body weight 
programming. Because AgRP and a subset of POMC neurons are leptin-sensing, we believe 
that the ontogeny of these two primary feeding centers may represent a critical node underlying 
the programmed establishment of obesity in offspring. In the following manuscript we will 
investigate the profile of Pomc and Npy-expressing populations over the course of development 
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Hypothalamic neuron circuits regulating energy balance are highly plastic and develop in 
response to nutrient and hormonal cues. To identify processes that might be susceptible to 
gestational influences in mice, we characterized the ontogeny of proopiomelanocortin (POMC) 
and neuropeptide Y (NPY) cell populations, which exert opposing influences on food intake and 
body weight. These analyses revealed that Pomc is broadly expressed in immature 
hypothalamic neurons and that half of embryonic Pomc-expressing precursors subsequently 
adopt a non-POMC fate in adult mice. Moreover, nearly one quarter of the mature NPY+ cell 
population shares a common progenitor with POMC+ cells. 
The rapid increase in the prevalence of childhood obesity and the concomitant rise in 
obesity-related medical morbidities and costs lend urgency to the need for new insights into the 
causes and potential preventive measures for this disease (Ogden et al., 2006). Mounting 
evidence supports the idea that the maternal environment can impart a lasting effect on the 
susceptibility of offspring to obesity and type 2 diabetes (Taylor and Poston, 2007). The arcuate 
nucleus of the hypothalamus (ARH) is a key component of the neuronal network regulating body 
weight, adiposity and glucose homeostasis, and recent studies suggest that the development of 
arcuate neurons may be sensitive to maternal metabolic status (Levin, 2006). The discovery 
that ARH projections are influenced by leptin provided the first insight into potential mechanisms 
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underlying 'maternal programming' in the perinatal period (Bouret et al., 2004). The gestational 
environment has also been shown to influence the future metabolic status of offspring (Shankar 
et al., 2008); however, little is known about the embryonic origins of arcuate lineages. 
The two best-characterized arcuate populations—orexigenic neurons expressing NPY (NPY 
neurons) and agouti-related protein (AgRP) and anorexigenic neurons expressing POMC 
(POMC neurons)—produce antagonistic effects on food intake in response to nutrient and 
hormonal signals of peripheral energy status (Saper et al., 2002). Signals of positive energy 
balance, such as leptin and glucose, stimulate subsets of POMC neurons, leading to decreased 
food intake while inhibiting the release of orexigenic peptides from neighboring NPY neurons 
(Cowley et al., 2001). NPY neurons are active when the energy supply is not sufficient to meet 
systemic demands, releasing AgRP and γ-aminobutyric acid (GABA) to inhibit melanocortin-
mediated suppression of food intake (Cowley et al., 2001; Ollmann et al., 1997). Together, NPY 
and POMC neurons integrate signals of energy homeostasis to direct physiological processes 
that regulate proper body weight (Schwartz and Porte, 2005). We focused our initial efforts on 
characterizing the ontogeny of NPY and POMC neuronal lineages during gestation because 
nutrient and hormonal cues influence the formation of NPY and POMC circuits, consistent with 
the idea that these developmental processes influence future metabolic phenotypes.  
Using the GenePaint digital mouse atlas, we found that Pomc expression starts at E10.5 
and that Npy expression begins at E14.5. Given the earlier onset of Pomc expression, together 
with the established lateromedial gradient of hypothalamic neurogenesis (Altman and Bayer, 
1978), we predicted that the lateral POMC neurons would differentiate before the medial NPY 
neurons. To determine the birth dates of POMC and NPY neurons in the ARH, we injected 
dams with a single pulse of BrdU between E11.5 and E16.5 and assessed the retention of the 
BrdU label by immunohistochemistry at postnatal day 9 (P9) (Supplementary Methods). We 
observed that the peak birth date of most cells in the ARH is E11.5–E12.5 (ref. (Shimada and 
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Nakamura, 1973) and Fig. 2.1a); however, BrdU injections at E13.5 labeled some cells in the 
lateral ARH (Supplementary Figs. 2.1 and 2.2). Analysis of BrdU labeling in conjunction with 
Pomc or Npy expression showed that POMC and NPY neurons are born within the same time 
window, E11.5–E12.5, and that later-born ARH populations are distinct (Fig. 2.1a–c). 
The shared birth dates of POMC and NPY neurons led us to consider whether the origins of 
these two antagonistic populations of neurons may be related. We characterized Pomc and Npy 
expression by two-color FISH across gestation (Fig. 2.1d,e). We first observed Pomc 
expression in the hypothalamic ventricular zone at E10.5–E11.5; from E12.5 on, expression was 
restricted to differentiated neurons, consistent with our birth-dating studies (Fig. 2.1d). The 
number of Pomc+ cells reached a maximum at E13.5, after which its expression was 
extinguished in more than half of the population between E14.5 and E18.5 (Fig. 2.1f). We did 
not observe Npy expression in the ventricular zone; we first detected it in laterally situated cells 
in the rostral aspect of the presumptive ARH at E13.5 (Fig. 2.1d). Subsequently, Npy+ cells are 
predominantly situated in the ventromedial ARH. We did not detect appreciable numbers of 
apoptotic cells by TUNEL staining (data not shown), which is consistent with the idea that Pomc 
expression is turned off in a large percentage of immature hypothalamic neurons (Broad et al., 
2009). These data argue that Pomc expression does not reflect the acquisition of a terminal cell 
fate. Rather, the gradual extinction of Pomc and progressive onset of Npy represent an ongoing 
maturation process that extends throughout gestation. Supporting this idea, POMC and NPY 
neurons do not acquire their terminal peptidergic phenotype until the postnatal period in rodents, 
as reflected by the gene encoding cocaine- and amphetamine-regulated transcript and Agrp 
expression, respectively (Cottrell et al., 2009; Nilsson et al., 2005). 
Pomc and Npy are expressed in mutually exclusive cell populations in adults (Pinto et al., 
2004), yet we detected Pomc+ and Npy+ colocalization at midgestation (Fig. 2.1e). To 
substantiate this unexpected finding that a subset of neurons express both Pomc and Npy, we 
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compared the expression profiles of NPY neurons isolated from embryonic and postnatal 
stages. We used FACS to collect GFP+ cells from Npy-hrGFP embryos, which express 
humanized Renilla green fluorescent protein (hr-GFP) under the control of Npy promoter and 
enhancer elements (van den Top et al., 2007). We detected Pomc transcripts by PCR on sorted 
cells from E14.5 but not from P9 (Fig. 2.1g and Supplementary Fig. 2.3a,b). These observations 
support the idea that during gestation a subset of Pomc-expressing cells can differentiate into 
NPY neurons. 
Next we used a genetic lineage tracing strategy (Zinyk et al., 1998) to visualize the mature 
POMC neuronal population, defined by Pomc expression in adults, in relation to the broad 
immature Pomc-expressing population in the embryo (Fig. 2.2). In this strategy, we used mice 
with Cre recombinase driven by Pomc regulatory elements to direct the excision of a loxP-
flanked stop codon (Pomc-Cre) upstream of a Gfp reporter knocked into the constitutively active 
ROSA26 locus (R26-GFP). In this way, cells that express Pomc from gestation are permanently 
marked (Balthasar et al., 2004). To assess Pomc transcriptional activity in conjunction with a 
GFP reporter, we developed a technique to combine images of direct GFP fluorescence with 
FISH (Supplementary Figs. 2.4 and 2.5). When we performed this assay on adult tissue from 
Pomc-GFP transgenic mice, 95% of Pomc-GFP+ neurons also expressed Pomc (Fig. 2.2a), 
validating the sensitivity of this technique (Cowley et al., 2001). In contrast, only half of the GFP+ 
cells in Pomc-Cre;R26-GFP mice expressed Pomc (Fig. 2.2b and Supplementary Fig. 2.6). 
Pomc-negative GFP+ cells in Pomc-Cre;R26-GFP adults probably represent cells that turned off 
Pomc expression at some point after E13.5. GFP+ cell counts in Pomc-Cre;R26-GFP mice were 
consistently twice as high as those generated by Pomc FISH or direct fluorescence in Pomc-
GFP–transgenic mice (Fig. 2.2d). 
Given our finding that Npy and Pomc colocalize in a subset of embryonic neurons, we 
considered whether some of the Pomc-negative GFP+ neurons in Pomc-Cre;R26-GFP adults 
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are NPY neurons. We detected Npy expression in 17% ± 2% of GFP+ neurons in adult Pomc-
Cre;R26-GFP mice (Fig. 2.2b). We used two strategies to independently verify this observation. 
First, confocal images of immunohistochemistry on Npy-GFP;Pomc-Cre;R26-LacZ mice 
confirmed that 25% of NPY (GFP+) neurons also express the Pomc-Cre lineage trace (β-
galactosidase immunohistochemistry) (Fig. 2.2c,e). Second, RT-PCR on FACS-purified GFP+ 
cells from Pomc-Cre;R26-GFP mice showed that some cells marked by the lineage trace 
express Npy (Fig. 2.2f and Supplementary Fig. 2.3c). 
These data provide evidence that a subpopulation of NPY neurons are derived from 
progenitors that are distinct from other ARH NPY neurons, raising the possibility that they serve 
different functions within the hypothalamic feeding circuit and, thus, may underlie the known 
heterogeneous electrophysiological properties of NPY neurons (Fioramonti et al., 2007). 
Although the origins of NPY subpopulations may differ, their subsequent differentiation 
converges on an orexigenic, GABAergic phenotype, as we found that all ARH NPY neurons 
express Agrp and the gene encoding glutamic acid decarboxylase-67, a rate-limiting enzyme in 
GABA synthesis (Cowley et al., 2001). A key area for future research is to use labeling 
techniques that distinguish between Pomc-derived and Pomc-nonderived NPY neurons in 
conjunction with analyses of gene expression profiles, neuronal architecture and 
electrophysiological properties. Classification of functionally distinct subsets of neurons derived 
from a Pomc+ lineage is crucial for elucidating how hormonal and nutrient signals are sensed by 
ARH neurons and relayed to downstream targets that regulate body weight and energy 
homeostasis. 
In this study, we have shown that Pomc is transiently expressed by the vast majority of cells 
in the developing ventral hypothalamus (Fig. 2.1d,f). During gestation, Pomc transcription is 
extinguished in more than half of these cells, some of which subsequently differentiate into NPY 
neurons and some of which adopt alternative terminal fates. Consistent with our FISH analyses, 
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when we used Pomc-Cre;R26-GFP mice to trace Pomc-derived lineages in the adult 
hypothalamus, we found that half of the GFP-labeled neurons are non-POMC neurons. This 
Pomc-Cre driver was developed as a tool to investigate the physiological consequences of 
POMC-specific loss or gain of gene function. As we demonstrated that recombination of floxed 
alleles is not limited to mature POMC neurons and includes a substantial portion of mature NPY 
neurons, previous functional studies using this Cre driver should be reanalyzed. Indeed, some 
functions ascribed to POMC neurons might be mediated by non-POMC neurons that expressed 
Pomc at one time in development. 
The observation that several functionally distinct cell types arise from a Pomc-expressing 
lineage raises the possibility that factors that influence cell fate decisions within the immature 
population during gestation could permanently affect the neuronal composition of circuits 
regulating energy homeostasis. Dietary manipulations during gestation have been associated 
with increased Pomc expression at postnatal stages, supporting the idea that maternal signals 
can influence the differentiation of the Pomc-expressing lineage (Chen et al., 2008). Two major 
areas for future research are to determine whether specific maternal nutrient or hormonal 
signals influence the differentiation or the architecture of neuronal lineages in hypothalamic 





Figure 2.1. Pomc is transiently expressed in a broad population of hypothalamic neurons during 
embryonic development. (a–c) We injected wild-type dams once with 200 mg per kg body 
weight BrdU at E11.5 and killed the offspring at P9 for analysis. (a) BrdU 
Immunohistochemistry. (b,c) Combined FISH with immunohistochemistry with probes against 
Pomc (b) or Npy (c) in conjunction with an antibody against BrdU and counterstained for DAPI. 
Magnified view of the boxed areas in the composite are shown at the bottom; individual layers 
from the boxed regions are shown at the left. (d) FISH for Pomc (green) and Npy (red) in ventral 
hypothalamus from E11.5 to E18.5. 3V, third ventricle. (e) Confocal image of a cell containing 
both Npy and Pomc transcripts at E14.5. (f) We counted cells expressing Pomc and Npy as 
described in Supplementary Figure 2.3. Each group represents the average counts of at least 
five coronal sections per mouse, spanning the rostrocaudal extent of the presumptive ARH, with 
error bars representing means ± s.e.m. (n ≥ 3 mice for each group). (g) Pomc and Npy 
expression, as assessed by PCR on cDNA generated from sorted GFP+ cells. We dissociated 
cells from transgenic Npy-hrGFP hypothalami and FACS-purified GFP+ cells at E14.5 and P9. –, 
no cDNA control; A, adult hypothalamus positive control; NG, Npy-hrGFP. Scale bars: a, 100 
μm; b,c, 50 μm (low magnification), 10 μm (high magnification); d, 50 μm; e, 5 μm; all tissues 







Figure 2.2. NPY neurons derived from a Pomc-expressing lineage persist to adulthood. (a,b) 
Images of direct GFP fluorescence obtained prior to FISH processing in Pomc-GFP (a left) or 
Pomc-Cre;R26-GFP (b left) adults, followed by FISH with Pomc alone (a center) or Pomc 
(green) plus Npy (red) probes (b center) or, composite images (a, b right) (technique described 
in Supplementary Fig. 2.5). (b) Cells expressing Npy and the Pomc-Cre lineage marker, GFP, 
are indicated with arrowheads. Because of its perinuclear localization, the FISH signal appears 
as a ring around the GFP signal. (a,b) All images acquired with a Nikon Eclipse 80i fluorescent 
microscope. (c) Confocal images of β-GAL IHC (red) in conjunction with direct GFP 
fluorescence (green) in Pomc-Cre;R26-LacZ;Npy-GFP adults. (d) Cell counts across the rostral-
caudal axis of the ARH for Pomc transcript (Pomc-FISH), direct fluorescence of GFP from 
Pomc-GFP adults or from Pomc-Cre;R26-GFP (Pomc-CRE) adults are compared. (e) High 
magnification image of the region boxed in c. (f) We dissociated hypothalamic cells from 
transgenic Pomc-Cre;R26-GFP mice and FACS-purified GFP+ cells at P9. Pomc and Npy 
expression, as assessed by PCR on cDNA generated from sorted GFP+ cells. Adjacent lane 
doublets separated by the grey bar were run simultaneously on the same gel but not in 
neighboring lanes; they have been juxtaposed for the purposes of this figure. Abbreviation for 
sources of cDNA: adult hypothalamus positive control (A); Pomc-Cre;R26-GFP (PCG). 3V, third 
ventricle; Scale bar (a–c) 100 µm, (e) 10 µm. Error bars representing mean ± SEM (n ≥ 42 






Animals were housed in temperature controlled rooms at 21 °C and subject to a 12 h light-
dark cycle. Mice had ad libitum access to standard chow diet (Lab Diet: PicoLab Rodent Diet 
5053) and water. C57BL/6 and (ROSA)26Sor-EGFP reporter (R26-GFP) mice  were obtained 
from the Jackson Laboratory and bred at the Russ Berrie Animal Facility (Soriano, 1999). Pomc-
Cre (Balthasar et al., 2004), Pomc-GFP (Cowley et al., 2001) and Npy-hrGFP (van den Pol et 
al., 2009) transgenic animals were generously provided by Joel Elmquist, Malcolm Low and 
Bradford Lowell respectively. All analyses were performed on mice which were Pomc-Cre Tg+ 
and homozygous for the R26-GFP allele. All procedures were performed in accordance with the 
guidelines of the Institutional Animal Care and Use Committee at the Columbia University 
Health Sciences Division. 
Genotyping 
Genotyping at the ROSA26 locus was performed using the following three-primer set: oIMR 
0883: 5’-AAAGTCGCTCTGAGTTGTTAT-3’;  oIMR 0315 5’-GCGAAGAGTTTGTCCTCAACC-3’; 
oIMR 0316 5’-GGAGCGGGAGAAATGGATATG-3’ (Soriano, 1999). Genotyping of Npy-hrGFP 
transgenic mice was performed using: NPY-ata-S-F: 5'-
TATGTGGACGGGGCAGAAGATCCAGG-3', NPY-ata-S-R: 5’-
CCCAGCTCACATATTTATCTAGAG-3’ and AA33 5'-GGTGCGGTTGCCGTACTGGA-3' (van 
den Pol et al., 2009). The Cre transgene was assessed with: 5’-
GCGGTCTGGCAGTAAAAACTATC-3’, 5’-GTGAAACAGCATTGCTGTCACTT-3’.  
Tissue Processing 
P9 and adult mice were anesthetized and perfused transcardially with 0.9% NaCl followed 
by 4% paraformaldehyde (PFA) in phosphate buffer (PB). Brains were post-fixed at 4°C 
overnight and cryoprotected with 30% sucrose for 48 h. For embryonic tissue, dams were 
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anesthetized with Avertin and embryos were dissected in cold PBS and fixed at 4 °C overnight 
and cryoprotected with 30% sucrose for 24 h. Tissue was embedded in O.C.T (Tissue Tek) and 
frozen at –80°C. 10 µm-thick coronal sections were collected across the rostral–caudal extent of 
the ARH on Superfrost Plus slides (Fisher).  
Fluorescent In Situ Hybridization 
Frozen sections were processed as described in the TSA Plus Cy3 System manual (Perkin 
Elmer). Antisense digoxigenin- or fluorescein-labeled riboprobes were generated from plasmids 
containing PCR fragments of Npy and Pomc using the following primers sets: (NPY) 5’-
TGCTAGGTAACAAGCGAATGG-3’/5’-CAACAACAACAAGGGAAATGG-3; (POMC) 5’- 
GTTAAGAGCAGTGACTAAGAGAGGC-3’/5’-CCTAACACAGGTAACTCTAAGAGGC-3’.   
Imaging and Quantification 
Fluorescent microscopy was performed using a Nikon Eclipse 80i equipped with a Retiga 
EXi camera and X cite 120 fluorescent illumination system. TIFF files were acquired using Q 
Capture Pro software (Qimaging) and analyzed using Adobe Photoshop. Because our studies 
involved comparisons of images of the same tissue captured at different times, we used 
a diamidino-2-phenylindole (DAPI) stain to establish a reference focal plane. Images were 
separated into independent RGB channels using Photoshop, and Cy3 or GFP signals were 
compared to signals in the DAPI channel (Supplementary Fig. 2.4). Cy3 or GFP signals that did 
not have a corresponding DAPI-stained nucleus were excluded from our counts.  
GFP fluorescence is lost during the high temperature hybridization step; thus, we pre-
imaged direct GFP fluorescence in conjunction with DAPI. Following FISH, the tissue was re-
stained with DAPI and imaged. Using Photoshop, pre- and post-FISH images were aligned 
using the common DAPI stain as a reference to generate a composite image (Supplementary 




Combined BrdU Immunohistochemistry and FISH 
To label proliferating cells, dams were given a single intraperitoneal (i.p.) injection of 5-
Bromo-2-deoxyuridine (BrdU) (200 mg kg-1 Sigma) on E11.5, E12.5, E13.5, E14.5 and E15.5. 
Offspring were sacrificed at P9 and processed as described above (cyroprotection in sucrose 
was reduced to 24 h). Detection of BrdU-labeled DNA by IHC requires DNA denaturation, which 
can be accomplished in many ways (Wojtowicz and Kee, 2006). We compared two pretreatment 
methods: standard 2.0 N HCl at 37 °C for 1 h, versus 50% formamide at 68 °C overnight. We 
found that both methods yield similar numbers of BrdU-positive cells with fluorescent IHC 
(Supplementary Fig. 2.1a,b). Because the same formamide treatment is also used in FISH 
hybridization step, we used this method to combine BrdU IHC with FISH.  
Day one of the FISH protocol was followed directly, except the permeabilization step was 
performed with 0.1% Triton X-100 (in PBS, 30 min) instead of proteinase K. Following the 
overnight hybridization plus denaturation step, sections were blocked for one hour in 2% normal 
horse serum; 0.1% Triton X-100 (Block Buffer) at room temperature.  Sections were then 
incubated overnight at 4 °C with the combination sheep anti-DIG-POD and rat anti-BrdU 
antibody (1:400, Novus Biologicals) in Block Buffer.  The following day, sections were treated 
with tyramide Cy3 for 10 min room temperature (described in Perkin Elmer TSA amplification 
kit), washed 3X in PBS and then incubated with goat anti-rat Alexa-488 (1:500, Invitrogen) for 
one hour at room temperature.  IHC with goat anti-β-Gal (1:4,000, Biogenesis) was performed 
without tyramide amplification. Slides were counterstained with DAPI (Invitrogen) and mounted 
with VectaShield (Vector Labs). 
FACS and PCR Analysis 
Hypothalamic tissue was dissociated as described by the Papain Dissociation System 
manual (Worthington). GFP+ cells were collected using a BD FACS Aria Cell Sorter by the 
Herbert Irving Cancer Institute facility, total RNA was isolated (Invitrogen) and cDNA was 
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reversed transcribed (Invitrogen). PCR was performed using the Npy and Pomc primers sets 
described above.  
Statistical Analysis   









Supplementary Fig. 2.1  Overnight incubation at 70 °C in 50% formamide can substitute for 
HCl pre-treatment to detect BrdU by IHC. (a,b) IHC detection of BrdU label retained at P9 in 
adjacent hypothalamic sections resulting from a single BrdU injection at E11.5. Similar numbers 
of BrdU-labeled cells were detected using the standard HCl pre-treatment at 37 °C for 1 h (a) 




Supplementary Figure 2.2 
 
 
Supplementary Fig. 2.2  A population of laterally situated cells in the ARH is born at E13.5. 
IHC on P9 hypothalamic sections to detect BrdU-labeled cells resulting from an E13.5 injection. 
3V, third ventricle. Scale bar: 100 µM 
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Supplementary Fig. 2.3  FACS isolation of GFP positive populations from dissociated 
ventral hypothalamic tissue. (a,b) Cells collected from Npy-hrGFP animals at E14.5 and P9 
respectively (see Figure 2.1g for corresponding PCR data). (c) Cells collected from Pomc-
Cre;R26-GFP animals at P9 (see Fig. 2.2f for corresponding PCR data).   
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Supplementary Fig. 2.4  Using DAPI stain as a criterion for cell counts. (Left) Pomc FISH 
image alone. (Center) The fluorescent signal from Pomc FISH (red) was imaged in conjunction 
with a DAPI counterstain (gray). To facilitate our analyses, the channel containing the DAPI 
image was copied to a separate layer, converted to grayscale and made semi-transparent in 
Photoshop. (Right) DAPI image alone. Fluorescent signals that did not overlap with DAPI stain 











Supplementary Fig. 2.5  Technique to analyze GFP expression in conjunction with FISH at 
the single cell level. (Left) Section from a Pomc-Cre;R26-GFP adult hypothalamus was pre-
imaged for direct GFP fluorescence (green) in conjunction with a DAPI counterstain (gray). 
(Right) FISH with a Pomc probe (red) was subsequently performed on the same section and 
imaged in conjunction with DAPI (gray). (Center)  Using the DAPI stains as a guide, images in 











Supplementary Fig. 2.6 Only half of the GFP-labeled cells marked by a Pomc-Cre;R26-
GFP genetic trace express Pomc in adults. Sectioned tissue from adult Pomc-Cre;R26-GFP 
animals was pre-imaged for direct GFP (green) fluorescence (Left), processed using FISH with 
a Pomc (red) probe (Right), and aligned on the basis of DAPI stain as described in 
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Chapter 3 “Defining POMC neurons utilizing transgenic reagents: Impact of transient 
Pomc expression in diverse immature neuronal populations.” 
Introduction 
In our previous study we detected transient Pomc-expression in many immature neurons of 
the mediobasal hypothalamus during the last week of embryogenesis. Furthermore, we found 
that as these cells differentiate into a variety of distinct functional populations, some of which 
inversely determine hypothalamic mediated effects on energy homeostasis. These studies have 
yet to conclude on role that Pomc expression plays during development or on the lineages of 
distinct populations in the ARH; however, one immediate goal based on these initial findings 
was to utilize Pomc-Cre reporters to investigate the properties of terminal cell fate decisions of 
immature Pomc-expressing cells. 
Hypothalamic POMC neurons function to mediate an anorexigenic effect on energy 
expenditure and food intake via the transmission of POMC-derived peptides to downstream 
secondary targets. While it has long been noted that Pomc is expressed in the mediobasal 
hypothalamus during embryogenesis, at a time prior to circuit formation, it has been generally 
disregarded by the field and otherwise noted as an early marker of cells destined for a mature 
POMC terminal fate. However, considering our findings in Chapter 2, it is unlikely that early 
Pomc-expressing cells indicate a POMC fate, exclusively. Literature focused on the developing 
retina and spinal cord demonstrate a role for POMC-derived proteins during cellular maturation, 
implicating these peptides in the differentiation and specification of cell fates in these aspects of 
the brain (Cossu et al., 1989; Eriksson et al., 1991; Hauser et al., 1996; Ilyinsky et al., 1987; 
Isayama et al., 1991; Lindqvist et al., 2003; Satoh and Ide, 1987; Vernadakis and Kentroti, 
1990).  
This chapter consists of a manuscript in preparation that aims to provide a comprehensive 
description of all neuronal populations in the CNS that are derived from Pomc-expressing 
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precursors. Importantly this data will provide a foundation to interpret previous studies using the 
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Defining POMC neurons utilizing transgenic reagents: Impact of transient Pomc 
expression in diverse immature neuronal populations. 
Manuscript in preparation 
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Abstract 
Melanocortin signaling plays a central role in the regulation of phenotypes related to body 
weight and energy homeostasis.  To specifically target and study the function of POMC 
neurons, Pomc promoter elements have been utilized to generate reporter and Cre 
recombinase transgenic reagents.  Across gestation, we find that Pomc is dynamically 
expressed in many sites in the developing mouse forebrain, midbrain, hindbrain, spinal cord and 
retina.  While Pomc expression in most embryonic brain regions is transient, it is sufficient to 
direct Cre-mediated recombination of floxed alleles.  We visualize the populations affected by 
this transgene by crossing Pomc-Cre mice to ROSA reporter strains and identify 62 sites of 
recombination throughout the adult brain, including several nuclei implicated in energy 
homeostasis regulation.  To compare the relationship between acute Pomc promoter activity 
and Pomc-Cre-mediated recombination at the single cell level, we crossed Pomc-eGFP and 
Pomc-Cre;ROSA-tdTomato lines.  We detect the highest concentration of Pomc-eGFP+ cells in 
the arcuate nucleus of the hypothalamus and dentate gyrus, but also observe smaller 
populations of labeled cells in the nucleus of the solitary tract, periventricular zone of the third 
ventricle and cerebellum. Consistent with the dynamic nature of Pomc expression in the 
embryo, the vast majority of neurons marked with the tdTomato reporter do not express GFP in 
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the adult. Thus, recombination in off-target sites could contribute to physiological phenotypes 
using Pomc-Cre transgenics. For example, we find that roughly half of the leptin-induced 
phospho-STAT3+ cells in the ARH are marked with Pomc-Cre;ROSA-tdTomato; only 15% of 
these are GFP+ POMC neurons.   
Introduction  
Severe obesity in mice lacking the Pro-opioimelanocortin (Pomc) or Melanocortin receptor 4 
(Mc4r) genes led to the widely-held belief that POMC neurons play a central role in regulating 
body weight (Huszar et al., 1997; Yaswen et al., 1999).  POMC and agouti-related peptide 
(AgRP) neurons located in the ARH are thought to be the principal source of MC4R ligands in 
the brain; however the contribution of signals from POMC neurons in the nucleus of the solitary 
tract (NTS) has not been well-defined.  A cleavage product of the POMC peptide, α-melanocyte 
stimulating hormone, and AgRP induce opposite effects on signaling via MC4R (Fan et al., 
1997; Ollmann et al., 1997). Observations that leptin signaling induces the expression of the 
POMC-derived agonist and inhibits the expression of the AgRP antagonist, led to the hypothesis 
that melanocortin (MC) circuits mediate leptin’s effects on energy homeostasis (Cowley et al., 
2001; Mizuno and Mobbs, 1999; Schwartz et al., 1996; Schwartz et al., 1997).   As these early 
seminal studies relied on pharmacological administration of leptin and/or MC antagonists and 
agonists, they could not distinguish between the contributions of discrete neuronal populations 
to energy homeostasis. 
Two types of genetically engineered mouse strains were generated to specifically target and 
interrogate the role of POMC neurons in leptin-responsive circuits. GFP reporters driven by 
Pomc promoter elements (Pomc-eGFP) (Cowley et al., 2001; Pinto et al., 2004) have been used 
to identify POMC neurons for electrophysiological and immunohistochemical analyses.  In 
addition, a Pomc-Cre BAC transgenic strain was developed to restrict genetic manipulations to 
POMC neurons and thus evaluate their function in vivo (Balthasar et al., 2004).  These seminal 
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studies using Pomc transgenic reagents serve as the basis for prevailing models of 
hypothalamic regulation of body weight and energy homeostasis.  
Previously we demonstrated that the Pomc-Cre transgene activity during gestation directs 
recombination of floxed alleles in many ARH neurons that do not express POMC in adulthood 
(Padilla et al., 2010).  In follow-up studies, we observed that Pomc is broadly expressed 
throughout the central nervous system (CNS) during development.  These observations raise 
the possibility that off-target effects in diverse populations in the CNS could contribute to 
physiological outcomes of genetic manipulations intended for POMC neurons.  To assist in 
interpreting experiments utilizing Pomc-Cre mice, we provide a comprehensive map of brain 
nuclei marked by Pomc-Cre-mediated combination of ROSA26-(loxSTOPlox)-LacZ (R26R-
LacZ) or ROSA26-(loxSTOPlox)-tdTOMATO (R26R-TOM) reporter strains (Madisen et al., 
2010; Soriano, 1999).  As MC and leptin pathways likely interact to regulate energy 
homeostasis, we characterized the relationship between leptin-induced phospho-STAT3 (P-
STAT3) immunoreactivity, neurons marked by a Pomc-Cre reporter, and those that express 
Pomc or Neuropeptide Y (Npy). 
As newer approaches to temporally restrict Pomc-Cre expression to adulthood are 
developed, it is important to determine whether off-target expression of Pomc-Cre reporters 
results from transient expression of Pomc during an earlier developmental stage or ectopic 
expression of the transgenic construct.  Thus, we compare the relationship between 
endogenous Pomc transcription, expression of a Pomc-eGFP reporter, and Pomc-Cre reporters 
at the single cell level in Pomc-eGFP; Pomc-Cre;R26R-TOM mice.  Going forward, temporal 
and spatial patterns of Pomc-eGFP and Pomc-Cre reporter expression should inform analysis 





Dynamic Pomc expression in the embryonic CNS 
Off-target sites of Pomc-Cre-mediated recombination could result from 1) early transient 
expression; 2) sub-threshold expression in the adult; or 3) ectopic expression in cells that do not 
express endogenous Pomc transcripts. Distinguishing between these possibilities is critical to 
developing reagents and strategies that accurately target POMC neurons. Initially we 
characterized Pomc expression in the developing embryo using a Pomc-eGFP reporter (Cowley 
et al., 2001).  In two independent transgenic lines, Pomc-eGFP reporter expression accurately 
reflects endogenous Pomc transcription in ARH neurons (Cowley et al., 2001; Padilla et al., 
2010; Pinto et al., 2004).  At embryonic day 12.5 (E12.5), we observe robust GFP signals in the 
presumptive ARH, retina, optic tract, midbrain and in a broad domain in the ventral hindbrain 
and spinal cord (Fig. 3.1A).  We first detect expression in the isthmus and pituitary at E13.5 (Fig. 
3.1B). We confirmed that these sites of GFP fluorescence correlate with Pomc expression, as 
visualized by in situ hybridization (Fig. 3.2, A-D). Prominent domains of GFP expression persist 
through E14.5 in the optic tract, ventral hypothalamus and isthmus; however, the fluorescent 
signal is dramatically decreased in the midbrain and hindbrain (Fig. 3.1C). Pomc expression in 
the developing pituitary steadily increases throughout gestation, in parallel with the maturation 
of this organ (Fig. 3.1, B and C). 
Distribution of Pomc-Cre activity 
We next examined whether transient Pomc expression in the embryo is sufficient to drive 
Cre-mediated recombination of floxed reporter allele.  At E16.5, we detect X-Gal-labeled cells in 
the hypothalamus, thalamus, midbrain, hindbrain, retina, olfactory bulb, spinal cord and dorsal 
root ganglia in Pomc-Cre;R26R-LacZ embryos (Fig. 3.2, E–H). In the periphery, we observe X-
Gal+ cells in the pituitary and duodenum, consistent with previously identified melanocyte and 
corticotrophic reservoirs (Cohen-Cory, 2002; Wolter, 1984) (Fig. 3.2, E and H).  Despite a 
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dramatic down-regulation of Pomc expression in caudal brain regions at E14.5 (Fig. 3.1C), we 
detect extensive X-Gal staining at E16.5, indicating that the transient burst of expression is 
sufficient to drive recombination of floxed alleles in many brain regions.   
To capture the cumulative distribution of cells that expressed Pomc at any point during 
development, we performed X-Gal staining on serial sections of Pomc-Cre;R26R-LacZ adult 
brains in both sagittal and coronal planes.  A comprehensive map of the density and distribution 
of X-Gal + neurons is presented in Table 1.  The lowest score, +/-, denotes regions with very 
few cells (significantly above background), while the highest score of +++++, represents regions 
with a majority of cells stained in a particular area (Table 1). Analysis of the density and 
distribution of stained neurons is rendered into dot-plot diagrams in 8 rostrocaudal and 2 
mediolateral planes of section, as described in the Methods section (Fig. 3.3). 
Hypothalamus and thalamus 
In the hypothalamus, we detect the highest density of X-Gal staining in the ARH and the 
posterior periventricular nucleus. In the ARH, X-Gal+ cells are distributed throughout the 
nucleus; with notable saturation along the ventral and lateral borders. We observe moderate 
staining density in the suprachiasmatic nucleus (SCN) and tuberal area, and low density 
staining in the ventromedial division of the ventral medial nucleus (VMH), retrochiasmatic 
nucleus and paraventricular nucleus (PVH). There are a few stained cells in the anterior 
hypothalamus, lateral and medial preoptic areas, medial mammillary nucleus, ventral 
premammilary nucleus and posterior hypothalamus. We consistently find sparse X-Gal staining 
in the zona incerta, supraoptic nucleus, dorsal medial hypothalamus and lateral hypothalamic 
area (Fig. 3.3 Bregma 0 to -1.4, and Table 1). In addition to the ARH, other hypothalamic nuclei 
that contain a substantial number of X-Gal+ cells also contribute to energy homeostasis. The 
SCN nucleus is the master regulator of circadian rhythms; disruption of circadian inputs leads to 
hyperphagia, obesity and insulin resistance (Turek et al., 2005). The VMH is thought to integrate 
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metabolic and reproductive functions and to modulate physiological responses to high fat diet 
(King, 2006; Yi et al., 2011).  Homeostatic, circadian and hedonic inputs from the hypothalamus 
and brainstem are integrated in the PVH and relayed to the periphery via neuroendocrine 
signals and efferent projections to the sympathetic nervous system (Tolson et al., 2010). 
In the rostral thalamus, we observe moderate X-Gal staining in the central medial and lateral 
dorsal nuclei, along with the nucleus of the reunions and paraventricular nucleus. We detect 
very low levels of expression in the medial habenula and mediodorsal nucleus (Fig. 3.3 Bregma 
-0.1, and Table 1). 
Hippocampus, olfactory bulb and septum 
 Outside of the ARH, we find the densest region of X-Gal staining in the granule cell layer 
of the dentate gyrus (DG), particularly in the medial and lateral blades. We observe moderate 
staining density in the presubiculum and in layers 1,2 and 3 of the subiculum, and a few X-Gal+ 
cells in the entorhinal area and in the parsubiculum.  In the rostral hippocampus, we detect a 
few X-Gal+ cells in the CA3 region. We observe sparse staining in the postsubiculum (Fig. 3.3 
Bregma -0.1, -1.4, -4.5, Lateral 0.2, 2.6, and Table 1). Processing of cognitive factors by the 
hippocampus is reported to influence feeding behavior and body weight, in part through effects 
on learning and memories related to food . For example, hippocampal ablations result in 
increased food intake and body weight, while leptin injections into the ventral hippocampus are 
reported to suppress food intake and processing of food-related memories (Davidson et al., 
2009; Forloni et al., 1986; Kanoski et al., 2011).  
In the olfactory bulb, we observe low levels of X-Gal stain in layers 1 and 2 of the cortical 
amygdalar area and also in layers 2 and 3 of the piriform area. We also detect staining in the 
taenia tecta and in the rostroventral aspect of the lateral septal nucleus (Fig. 3.3 Bregma 1.4, 0 
and Table 1). Olfactory circuits modulate appetite and food intake in response to select odors 
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(Shen et al., 2005), and in turn, the sensitivity of odor detection is influenced by prandial state 
and leptin signaling (Aime et al., 2007; Prud'homme et al., 2009). 
Cerebral cortex 
We observe moderate levels of expression in the bed nucleus of the stria terminalis (BNST) 
and the medial amygdalar nucleus. The BNST receives afferent input the parabrachial nucleus 
(PB), which is reported to elicit potent orexigenic effects on food intake (Wu et al., 2009), and 
also from NPY/AgRP neurons in the ARH (Saper and Loewy, 1980; Shin et al., 2008). The 
medial amygdala plays a critical role in regulating behavioral stress response, and lesions of the 
medial amygdala significantly attenuate chronic stress-induced weight gain (Solomon et al., 
2010).  In addition, we detect a few X-Gal+ cells in the basomedial amygdalar nucleus, the 
primary somatosensory area (layers 3 and 4) and in layer 4 of the cerebral cortex. We find 
sparse staining in the primary motor area and in the primary somatosensory barrel field (Fig. 3.3 
Bregma -0.1, -1.4 and Table 1). 
Midbrain, pons and medulla 
In the midbrain, we find a moderate density of X-Gal staining in the limbic interpeduncular 
fossa. We also observe a few stained cells in the inferior colliculus, parabigeminal, medial basal 
reticular nucleus and the superior colliculus. The periaqueductal gray and the ventral tegmental 
area contain sparse staining (Fig. 3.3 Bregma -5.0, -5.7 and Table 1). 
In the pons, we detect a low density of X-Gal staining in the external lateral division of the 
lateral PB (lPB). The PB nucleus mediates conditioned taste aversion and more recently, has 
been shown to receive inhibitory inputs from ARH neurons that influence feeding behavior (Wu 
et al., 2009). We detect a few X-Gal+ cells in the pontine central gray, with sparse staining in 
the pontine reticular nucleus and the principal sensory nucleus of the trigeminal (Fig. 3.3, 
Bregma -4.5, -5.0, -5.7 and Table 1).  
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In the medulla, we observe strong staining in the cochlear nucleus and moderate staining in 
the area postrema (AP). The facial motor nucleus, the medial aspect of the nucleus of the 
solitary tract (NTS) and the spinal nucleus of the trigeminal have low levels of X-Gal+ staining. 
We find sparse staining in the parvicellular reticular and vestibular nuclei (Fig. 3.3, Bregma -7.8, 
Lateral, 0.2, 2.6 and Table 1). The caudal brain stem integrates hypothalamic and vagal inputs 
with circulating gut and satiety signals, and influences processes related to food intake and 
energy expenditure in the periphery via the autonomic nervous system (Crawley and Schwaber, 
1983; Grill et al., 2002; Munzberg et al., 2003).  Lesions of the AP and NTS independently result 
in hypophagia accompanied by substantial reductions in body weight (Contreras et al., 1982; 
Menani et al., 1996).  
Cerebellum 
We detect X-Gal+ cells in the cerebellum of the mature brain (Fig. 3.4). To determine which 
cerebellar subtypes are affected by the Pomc-Cre transgene, we performed fluorescent 
immunohistochemistry (IHC) in sections from Pomc-Cre;R26R-TOM mice.  First we confirmed 
that the distribution of cells labeled in Pomc-Cre;R26R-TOM mice matches/recapitulates the 
pattern observed in Pomc-Cre;R26R-LacZ mice.  Next we assessed TOM reporter expression in 
conjunction with NeuN and parvalbumin (PV) immunoreactivity, to identify granule cells and 
stellate cells, respectively (Doyle et al., 2008). TOM+ cells are found throughout both the 
nuclear and molecular layers of the cerebellum. TOM+ cells in the nuclear layer co-express the 
granule cell marker NeuN (Fig. 3.4A), whereas many TOM+ cells in the molecular layer co-
express PV (Fig. 3.4, B and C). While Purkinje cells are not marked with the lineage trace, 
TOM+ fibers (Fig. 3.4 B arrows) are observed in close proximity to their large soma. 
Comparison of Pomc-eGFP vs. Pomc-Cre reporters 
As both Pomc-eGFP and Pomc-Cre transgenic lines have been used as the basis for 
studies of POMC neuronal activity, connectivity and function, we directly compared sites of 
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Pomc promoter activity with those marked by Pomc-Cre-mediated recombination in Pomc-
eGFP;Pomc-Cre;R26R-TOM mice, which express both types of reporter. Confirming previous 
reports, we observe Pomc-eGFP+  cells in the ARH, DG, AP and NTS (Bronstein et al., 1992; 
Knigge et al., 1981; Overstreet et al., 2004) (Figs. 3.5 and 3.6). In the ARH, all GFP+ cells co-
express the Pomc-Cre;R26R-TOM reporter. Consistent with our previous analyses/studies, we 
find that many TOM+ cells do not express the Pomc-eGFP reporter (Fig. 3.5, A-C) (Padilla et 
al., 2010). The only other site where we observe Pomc-eGFP+ cells in the hypothalamus is in 
the ependymal zone of the third ventricle, adjacent to the PVH and DMH; however, cells in this 
region are not marked with the Pomc-Cre;R26R-TOM reporter (Fig. 3.6 C).  
In addition to the periventricular hypothalamus, we can identify Pomc-eGFP+ cells that do 
not express TOM in the DG, cerebellum and caudal brainstem.  In the DG and CA3, we find that 
GFP and TOM reporter expression is nearly mutually exclusive, with GFP+ cells in the 
subgranular zone and TOM+ cells in the adjacent granular layer of the DG and CA3 at both P9 
and in adulthood (Fig. 3.6,  A and D). Pomc-eGFP+ cells in the subgranular region of the DG 
are reported to be/purported/may represent a transient population of immature neurons derived 
from a neurogenic niche in adults (Overstreet et al., 2004).  
The physiological properties of POMC neurons in the AP and caudal NTS are a subject of 
ongoing debate, as some studies found that subsets of these cells are stimulated by the 
anorexigenic hormones cholecystokinin and leptin, while others reported that Pomc-eGFP+ 
cells in the NTS do not transduce leptin signals (Ellacott et al., 2006; Huo et al., 2006). We 
detect Pomc-eGFP+ cells in both the AP and NTS. In the AP a minority of GFP+ cells co-
express TOM (35%± 8 of GFP+ are TOM+, Fig. 3.5 D-arrows), whereas in the NTS we find that 
TOM and GFP label mutually exclusive/non-overlapping neuronal populations (Fig. 3.6 F). In the 
cerebellum we also detect Pomc-eGFP+ cells that do not express the Pomc-Cre reporter, 
similar to the cells described in the ependymal zone of the third ventricle, the subgranular region 
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of the DG and in the NTS.  These GFP+ cells are localized to the medial and caudal cerebellum 
at P9, a period of external granule layer proliferation (Hatten and Heintz, 1995); however, in the 
adult, GFP+ cells are distributed throughout the rostro-caudal extent of the molecular cell layer 
(Fig. 3.6, B and E).   
In contrast to ARH, where nearly all Pomc-eGFP+ neurons are also labeled with a Pomc-
Cre reporter, GFP and TOM expression patterns in the hypothalamic periventricular zone, DG 
and NTS are largely discordant/complementary.  We used two in situ hybridization protocols to 
determine whether we can detect a Pomc signal in any of these sites - a tyramide-based 
amplification system (TSA-kit, Perkin-Elmer) and a more sensitive neutravidin-based 
amplification system (Lein et al., 2007).  In the NTS, we are able to detect the presence 
of/visualize Pomc transcripts using the Neutravidin system, but not with TSA system (Fig. 3.7). 
We did not detect a Pomc signal using either in situ system in the AP, DG or lPB (data not 
shown).   
Peptidergic identities of leptin-sensing neurons in the ARH and caudal brainstem 
Pomc-expressing populations in both the ARH and NTS have been implicated in the 
regulation of energy balance, in part, through transduction of leptin signals.  To determine 
whether cells expressing Pomc-eGFP and/or Pomc-Cre reporter cells are leptin-sensing, we 
assessed P-STAT3 immunoreactivity in conjunction with GFP and TOM in adult brains following 
a peripheral leptin injection.  Consistent with published analyses (Munzberg et al., 2003; 
Williams et al., 2010), we find that approximately 40 percent of mature POMC neurons in the 
ARH are P-STAT3+ following leptin treatment (Fig. 3.8 A, of 18±4 GFP+ cells, 7±3 cells are P-
STAT3+).  We also observe that approximately half of the TOM+ cells that do not co-express 
GFP in the ARH are leptin-sensing (Fig. 3.8 A, of 87±4 TOM-only, 47±2 are P-STAT3+); 35% of 
these non-POMC TOM+/P-STAT3+ cells are NPY neurons (Fig. 3.8 A, of 47±2 TOM only/P-
STAT3+, 13±3 also express NPY).  Thus, whereas POMC neurons represent a mere 14% of the 
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total number of leptin-sensing neurons in the ARH, the Pomc-Cre transgenic affects 70% of this 
population.  
In the AP, we find that 30 percent of the TOM+ population is leptin-sensing (Fig. 3.8 D, of 
20±3 TOM+, 11.8±4 are P-STAT3+). In the NTS, there are relatively few TOM+ cells compared 
to GFP+, none of which are leptin sensing. However, consistent with previously published 
reports, we find that approximately 50 percent of the GFP+ population in the medial NTS are 
leptin-sensing (Fig. 3.8 E, in an average of 21±2 GFP-only cells, 10±1 are P-STAT3+) (Ellacott 
et al., 2006).   
Discussion 
Pomc-eGFP and Pomc-Cre transgenic mouse lines have been used extensively to 
investigate the role of melanocortin circuits in regulating energy homeostasis.   In previous 
studies, we demonstrated that nearly all Pomc-eGFP+ cells in the adult ARH express Pomc 
transcript, whereas many cells marked with a Pomc-Cre reporter are devoid of a Pomc ISH 
signal and/or Pomc-eGFP reporter expression (Padilla et al., 2010). Our data further indicated 
that this phenomenon was due to down-regulation of Pomc-expression in a broad region of the 
mediobasal hypothalamus during embryogenesis. Similar findings of transient Pomc expression 
have been reported in the embryonic spinal cord, where POMC processing products/derivatives 
may promote/regulate differentiation and proliferation of motor neurons (Berry and Haynes, 
1989; Haynes, 1990).   In our initial assessment/characterization of Pomc-eGFP and Pomc-
Cre;R26R-LacZ reporter distribution at embryonic stages, we noticed that X-Gal+ neurons were 
widely distributed throughout the brain, spinal cord and retina.  As recombination of a floxed 
allele is permanent, analyses of functional studies using the Pomc-Cre transgenic line could be 
complicated due to overlapping expression patterns of the transgene and gene of interest in 
other CNS sites at an earlier developmental stage.  To assist in the analysis of 
completed/existing studies involving the Pomc-Cre transgene, as well as to facilitate the design 
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of future experiments, we systematically characterized the distribution of cells marked with 
Pomc-Cre and Pomc-eGFP reporters across the murine brain at E16.5 and in the adult. 
Pomc-eGFP reporter as a marker of endogenous Pomc transcription 
Consistent with previous studies, we find that nearly all Pomc-eGFP+ cells in the embryonic 
and adult ARH express Pomc transcript (Cowley et al., 2001; Padilla et al., 2010; Pinto et al., 
2004).  Moreover, we observe a close correspondence between domains of Pomc-eGFP+ cells 
and Pomc expression in the embryonic pituitary, midbrain and hindbrain and spinal cord (Figs. 
3.1B and 3.2A).  Therefore, these transgenic lines are well-suited for use in neuroanatomical or 
electrophysiological studies of POMC neurons in the ARH.  
In several brain regions outside of the ARH (including the DG, periventricular zone of the 
dorsal hypothalamus, and cerebellum) we and others have identified Pomc-eGFP+ cells that do 
not express detectable levels of Pomc transcript (Fig. 3.6, (Overstreet et al., 2004)). We 
considered three possible explanations for these findings: 1) Pomc is expressed below the level 
of detection for this assay; 2) transient bursts of transcription are preserved by the persistence 
of GFP protein after transcription is extinguished; and 3) ectopic activation of the transgene.  
Using highly sensitive ISH methods, such as radioactive and Neutravidin-amplified detection 
systems, we and others detect Pomc transcripts in the NTS (Fig. 3.7 and (Bronstein et al., 
1992).  As the integrity of fluorescent reporter staining is not maintained under the conditions 
needed for Neutravidin-amplified detection, we could not assess the relationship between the 
Pomc-expressing cells in the NTS and those marked with either Pomc-eGFP or a Pomc-Cre 
reporter. We were unable to detect a Pomc signal in the DG, ependymal layer of the 3rd 
ventricle, or cerebellum using the Neutravidin-based system; however, others have reported low 
levels of Pomc transcription by PCR amplification from the rat cortex and cerebellum 
(Grauerholz et al., 1998).    Together these data support the idea that Pomc-eGFP expression in 
the NTS and in some extra-ARH brain regions reflect sub-threshold or transient Pomc 
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transcription, but we cannot exclude the possibility that some sites of GFP+ cells result from 
ectopic expression of the transgene.  
Interpretation and design of functional studies using Pomc-Cre transgenic lines 
Pomc-Cre transgenic mice have been utilized to conditionally target and study the function 
of POMC neurons in the hypothalamus. The phenotypes reported in these studies include 
effects on lipid metabolism, fertility, sexually dimorphic effects on glucose homeostasis and 
body weight phenotypes, food intake, locomotor activity, energy expenditure and alterations in 
soma size (Balthasar et al., 2004; Banno et al., 2010; Hill et al., 2010; Huo et al., 2009; Mori et 
al., 2009; Shi et al., 2010; Xu et al., 2007). We find that not only does this Cre line direct 
recombination to more cells than expected in the ARH, it is also present in other regions of the 
brain implicated in energy homeostasis including: PVH, VMH, subiculum, medial amygdala, lPB 
and AP (Table 3.1, Fig. 3.3). 
Previously we determined that Pomc-Cre directs recombination to a subset of AgRP/NPY 
neurons in the ARH (Padilla et al., 2010).  In this study we find that the absolute number of 
NPY/AgRP neurons labeled with the Pomc-Cre lineage trace varies, depending on the reporter 
allele used (25% with Rosa-eGFP vs. 70% with Rosa-LacZ and/or Rosa-tdTOM), ((Padilla et al., 
2010) and Fig 3.8B). Approximately 40% of ARH neurons are labeled with the TOM reporter; 
many of these do not express Pomc or Npy in adulthood (Padilla et al., 2010). As distinct ARH 
neuronal subpopulations are physically intermingled and project to similar downstream targets, 
the use of Pomc-Cre transgenes as part of a strategy to genetically label cell bodies or 
projection patterns or to characterize electrophysiological properties of POMC neurons is not 
advisable.  
Depending on the experimental design, off-target Pomc-Cre-mediated recombination could 
complicate the interpretation of conditional gain- or loss-of gene function studies.  The two most 
important considerations in analyzing phenotypes from genetic manipulations using Pomc-Cre 
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transgenes are: 1) the endogenous expression pattern of the gene of interest in relation to sites 
listed in Table 1; and 2) the timing of Pomc-Cre expression.  When the gene of interest is 
broadly expressed in the CNS, off-target effects in nuclei with moderate to high X-Gal staining 
could also contribute to body composition and metabolic outcomes.  If a target gene is not 
expressed in any of the neurons marked with the lineage trace, all resulting phenotypes can be 
attributed to POMC neurons.  
Even if a gene of interest has a restricted expression pattern, the severity of phenotypes 
could be mitigated by simultaneous genetic manipulations in NPY/AgRP and POMC neurons, 
which are thought to play opposing functions in circuits regulating body composition and energy 
homeostasis. In addition, non-POMC/NPY neurons marked with Pomc-Cre could also contribute 
to physiological outcomes.  In our analysis of the peptidergic identities of leptin-sensing cells in 
the ARH, we find that 70% of P-STAT3+ cells are TOM+ (of 65±4 P-STAT3+ cells, 54±2 are 
TOM+, Fig. 3.8). Of the leptin-sensing neurons affected by the Pomc-Cre transgene, 30% 
express Pomc, 55% express Npy, and the remaining 15% have yet to be defined (of 54±2 P-
STAT3+/TOM+, 14±1 are POMC+, 30±6 are NPY+).  
As many off-target sites of Pomc-Cre reporter activity result from transient Pomc expression 
during gestation, delaying transgene expression to adulthood would reduce the opportunity for 
unintended Pomc-Cre-mediated recombination events. For example, by injecting a viral 
construct expressing a floxed target gene into the adult ARH of Pomc-Cre mice, recombination 
should be limited to POMC neurons (Aponte et al., 2011).  In theory, activation of an inducible 
Pomc-Cre transgene in adulthood should also reduce off-target recombination.  While strategies 
to spatially and/or temporally restrict Pomc-Cre expression can limit unintended recombination 





Discordace between Pomc transcription, Pomc-eGFP and Pomc-Cre reporter expression 
In the ARH we conclude that Pomc-expressing cells, marked by Pomc-eGFP, co-express 
the Pomc-Cre reporter; however, in extra-ARH regions of the brain including the DG, 
periventricular zone of the dorsal hypothalamus, NTS and cerebellum, Pomc-eGFP+ cells do 
not follow this trend. For example, in the DG, GFP and TOM are expressed in mutually 
exclusive neighboring cellular populations, whereas in the cerebellum we detect TOM in a 
subset of the broad GFP+ population. Some possibilities to explain these observations are 
discussed below and involve both the potential role of POMC processing products in the 
maturation of immature neurons and/or the potential of extopic reporter expression. 
In the DG, Pomc-eGFP is expressed in an immature population in the subgranular zone, 
while the Pomc-Cre reporter is detected in a juxta-population of cells in the granular layer (Fig. 
3.6D).  These findings are consistent with previous reports that Pomc-eGFP is transiently 
expressed in newly-born neurons in the adult hippocampus, which extinguish the Pomc driven 
transgene as they mature and migrate out into the granular layer (Overstreet et al., 2004). The 
most parsimonious explanation of the pattern of reporter expression we observe in the DG is 
that the Pomc-eGFP and Pomc-Cre transgenes are transiently expressed in immature neurons 
in the subgranular layer, which are extinguished upon maturation and migration to the granular 
layer.  Detection of the Pomc-Cre lineage trace in the granular layer and not in the subgranular 
layer could be a result of the delay in Cre-mediated recombination of floxed reporter alleles 
relative to the onset of Cre expression (Branda and Dymecki, 2004).  While we cannot exclude 
the possibility that the Pomc-eGFP and Pomc-Cre transgenes are ectopically expressed in the 
subgranular layer and the granular layer of the DG, respectively, it is striking to find the 
expression of both Pomc transgenes in adjacent populations that reflect different stages of 
maturation of the same cell type. 
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The neighboring pattern of cells expressing Pomc-eGFP and Pomc-Cre reporters found in 
the DG, is similarly reflected in the periventricular zone of the dorsal hypothalamus and in NTS. 
GFP+ cells in the hypothalamus are adjacent to the ventricular zone – a proposed site of 
neurogenesis (Xu et al., 2005) – while Pomc-Cre reporter+ cells occupy more dorsal and lateral 
aspects of the PVN and DMH (Fig. 3.6C). In the medulla, GFP+ cells are located in a medial 
cluster of the commissural NTS, while Pomc-Cre reporter+ cells occupy the more dorsolateral 
regions of this nucleus (Fig. 3.6F). Unlike the DG, neither of these neighboring populations are 
immediately adjacent to one another, therefore determining the origin of the Pomc-Cre reporter+ 
cells remains speculative. Because the GFP+ hypothalamic periventricular cells are near a 
proposed neurogenic niche, it is likely that Pomc is expressed transiently in immature neurons, 
playing a role in the maturation of these newly born cells. While it is also possible that the GFP+ 
cells in the NTS are immature, we also detect low levels of Pomc expression in the medial 
commissural NTS (Fig. 3.7B), and thus it is also possible that such low levels of transcript are 
not sufficient to drive recombination. In this case, Pomc-Cre reporter+ cells in the NTS may be 
derived from Pomc-expressing precursors at an earlier stage of development, consistent with 
the detection of transient Pomc expression in the hindbrain during embryogenesis (Figs. 3.1 and 
3.2, A and D). 
Unlike the situations described above, Pomc-eGFP and Pomc-Cre reporters are not entirely 
mutually exclusive of one another in the cerebellum but rather are co-expressed in subsets of 
these reporter-expressing cells. During development at P9 – a stage of external germinal layer 
proliferation in the cerebellum (Hatten and Heintz, 1995) – GFP and TOM reporters are present 
in adjacent cell populations (Fig. 3.6B), consistent with the idea of transient expression. In adult, 
GFP expression is not as restrictive but rather scattered throughout all layers of the cerebellum, 
and is not particularly localized near the reported site of neurogenesis in the subpial layer (Ponti 
et al., 2006, 2008). While we cannot detect Pomc expression in the cerebellum under any 
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condiditions, others have found low levels of transcript using quantitave PCR.  If the q-PCR data 
is accurate, very low levels of expression may be present in the GFP population, while Pomc-
Cre reporter+ cells devoid of GFP reporter may have been derived from transient Pomc 
expression during earlier stages of development. 
Together, these observations raise the intriguing possibility that Pomc-eGFP expression 
outside the ARH regions could be a marker for immature neurons that were born in the adult or 
may also represent cells that express very low levels of Pomc transcript (perhaps below the 
level necessary to drive recombination via Pomc-Cre.  Further studies are needed to explore 
this hypothesis; however, if proven true, Pomc-eGFP expression could provide a powerful new 




Animals were housed in temperature controlled rooms at 21 °C and subject to a 12 h light-
dark cycle. Mice had ad libitum access to standard chow diet (Lab Diet: PicoLab Rodent Diet 
5053) and water. C57BL/6, ROSA(26R)-TOM and ROSA(26R)-LacZ mice  were obtained from 
the Jackson Laboratory and bred at the Russ Berrie Animal Facility (Madisen et al., 2010; 
Soriano, 1999). Pomc-Cre (Balthasar et al., 2004) and Pomc-eGFP (Cowley et al., 2001) 
transgenic animals were generously provided by Joel Elmquist/Bradford Lowell and Malcolm 
Low, respectively. All procedures were performed in accordance with the guidelines of the 
Institutional Animal Care and Use Committee at the Columbia University Health Sciences 
Division. 
Genotyping 
Genotyping at the ROSA26 locus for LacZ was performed using the following three-primer 
set: oIMR 0316 (wt-F) 5’-GGAGCGGGAGAAATGGATATG-3’; oIMR 0883 (wt-R): 5’-
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AAAGTCGCTCTGAGTTGTTAT-3’;  oIMR (mutant-LacZ) 0315 5’-
GCGAAGAGTTTGTCCTCAACC-3’; (Soriano, 1999). Genotyping at the ROSA26 locus for TOM 
was performed using a three-primer set including both wild type (wt) primers (0316 & 0883) 
above and, oIMR (mutant-TOM) 5’-CTGTTCCTGTACGGCATGG-3’ (Madisen et al., 2010). The 
Cre transgene was assessed with: 5’-GCGGTCTGGCAGTAAAAACTATC-3’, 5’-
GTGAAACAGCATTGCTGTCACTT-3’.  
Tissue processing 
P9 and adult mice were anesthetized and perfused transcardially with 0.9% NaCl followed 
by 4% paraformaldehyde (PFA) in phosphate buffer (PB). Brains were post-fixed at 4°C for 3 
hours and cryoprotected using a 30% sucrose gradient. For embryonic tissue, dams were 
anesthetized with Avertin and embryos were dissected in cold PBS and fixed at 4 °C overnight 
and cryoprotected. Tissue used for IHC and/or FISH was embedded in O.C.T. (Tissue Tek) and 
frozen at –80°C. 10 µm-thick coronal sections were collected across the rostral–caudal extent of 
the ARH on Superfrost Plus slides (Fisher). Alternatively, tissue used for X-Gal staining was not 
cryoprotected following fixation, but rather immediately processed for whole mount staining. 
X-Gal staining 
Following fixation, whole mount tissue was washed thoroughly in PBS at 4°C, and then 
permeabilized using 2 mM MgCl2, 0.001% sodium deoxycholate, and 0.02% NP-40 buffer, at 
room temperature for 2 hours. X-Gal staining was performed using 5 mM potassium 
ferricyanide, 5 mM potassium ferrocyanide, 20 mM Tris, and 1 mg/ml X-Gal, overnight at room 
temperature. After staining, the tissue was rinsed in PBS and fixed in 4% paraformaldehyde 
overnight. Embryonic tissue was subsequently cleared in glycerol and imaged as a whole mount 






The density of positive X-Gal staining in each brain nucleus, expressed as a percentage of 
total nuclear area, was used to determine the scores assigned to the nuclei as follows: 0-2 
percent scored +/-, 2-8% +, 8-14% ++, 14-30% +++, 30-50% ++++, and >50% +++++.   
Imaging 
Fluorescent microscopy was performed using both a Zeiss LSM5 Pascal Confocal or a 
Nikon Eclipse 80i equipped with a Retiga EXi camera and an Xcite 120 fluorescent illumination 
system. Bright field microscopy was performed with a Nikon Eclipse 80i camera. Tiled images 
acquired for dot renderings were obtained using an automated stage with Q Capture Pro 
imaging software (Qimaging).  
Dot rendering 
Regions with X-Gal+ cells categorized relative to the Allen Reference Atlas 
(http://www.brain-map.org, (Lein et al., 2007)). Stain density in each designated nucleus was 
quantified and rendered into dots using Adobe Photoshop. Within each individual nucleus, dot 
number is proportional to the area of the stain and dot placement reflects the spatial distribution 
of stained cells (note: dots were not assigned to nuclei with <2% total stain). 
IHC 
Fixed slide-mounted sections were blocked in 2% normal horse serum; 0.1% Triton X-100 
(Block Buffer) at room temperature.  Primary antibody incubation was performed using either 
guinea pig anti-GFP (1:2000; Molecular Probes) or rabbit anti-P-STAT3 (1:800; Cell Signaling) 
at 4 °C overnight.  Tissue was then washed in PBS and incubated in with secondary using 
either goat anti-guinea pig Alexa-488 (1:500 Invitrogen) or goat anti-rabbit cy5 (1:100 Jackson 
ImmunoResearch), for one hour at room temperature. Note, for P-STAT3 IHC an additional 
unmasking step was performed prior to blocking and primary antibody incubation by the 
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following sequential pretreatment: 1% NaOH with 1% H2O2 solution, 0.3% glycine, and 0.3% 
SDS. 
Combined IHC and FISH 
Procedures performed according to previously published methods (Padilla et al., 2010). 
FISH and NeutrAvidin amplified ISH 
Frozen sections were processed as described in the TSA Plus Cy3 System manual (Perkin 
Elmer).   Antisense digoxigenin- or fluorescein-labeled riboprobes were generated from 
plasmids containing PCR fragments of Npy and Pomc using the following primers sets: (NPY) 
5’-TGCTAGGTAACAAGCGAATGG-3’/5’-CAACAACAACAAGGGAAATGG-3; (POMC) 5’- 
GTTAAGAGCAGTGACTAAGAGAGGC-3’/5’-CCTAACACAGGTAACTCTAAGAGGC-3’.  
NeutrAvidin amplified ISH was achieved using biotinylated-tyramide (Perkin Elmer) in 
conjunction with NeutrAvidin Protein, Alkaline Phosphatase Conjugated (Thermo Scientific) 
followed by BCIP/NBT staining. 
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FIG. 3.1. Transient expression of a Pomc-eGFP transgenic reporter during gestation. 
Representative fluorescent images (magnification 1.6X) of the ventricular surface of hemisected 
embryonic brains at (A) E12.5; (B) E13.5; and (C) E14.5. All images are presented rostral, left. 






FIG. 3.2. Pomc is broadly distributed in the embryonic CNS and periphery. (A) E13.5 Pomc ISH. 
(B-D) Magnified views of the ARH (A), Pituitary (B) and hindbrain (C). (E) E16.5 Pomc-
Cre;R26R-LacZ embryo stained with X-Gal. (B-D) Magnified views at the level of the retina (B), 
hindbrain (C) and spinal cord (D) denoted in (A). Abbreviations: ARH, arcuate nucleus of the 
hypothalamus; R, retina; SC, spinal cord; DRG, dorsal root ganglia; arrowhead (C) developing 






FIG. 3.3. Line drawings to illustrate the distribution of neurons labeled with the Pomc-Cre;R26R-
LacZ  reporter in the adult brain. Dot plots are rendered from X-Gal-stained Pomc-Cre;R26R-
LacZ brains (200μm thick sections in the coronal and sagittal planes) and labeled with atlas 
coordinates (Lein et al., 2007). The density of dots directly corresponds to the density of X-Gal 






FIG. 3.4. Pomc-Cre;R26R-TOM reporter is observed in the molecular and nuclear layers of the 
adult cerebellum. (A-C) Direct TOM fluorescence is visualized in conjunction with IHC for: NeuN 
(A); Calbindin (B); Parvalbumin (C) IHC staining (left panels) appears green in the merged 
image (right panels), while TOM fluorescence (center panels) appears red in merged images 
(right panels) (B) Arrows indicate TOM+ fibers. (C) Arrows indicate TOM/Parvalbumin co-







FIG. 3.5. POMC neurons represent a minority of the cells labeled with a Pomc-Cre;R26R-TOM 
reporter in adulthood. (A-F) Confocal images of direct TOM fluorescence in conjunction with IHC 
for GFP in 10μm sections from adult Pomc-eGFP;Pomc-Cre;R26R-TOM animals. (A, B) Low 
magnification (4X) images of GFP+ (A) and TOM+ (B) populations in the hypothalamus at the 
level of the ARH. (C,D) Higher magnification (20X) images of the ARH (C) and AP (D). For each 
section, GFP IHC is in the left panel, direct TOM fluorescence is in the center panel, and 
merged composites are in the right panels. (D) Arrows indicate double positive GFP/TOM cells. 






FIG. 3.6. Expression of the Pomc-eGFP reporter in the absence of a Pomc-Cre;R26R-TOM 
reporter is observed in several brain regions in Pomc-eGFP;Pomc-Cre;R26R-TOM mice. (A, B) 
2X images of direct GFP and TOM fluorescence visualized from the ventricular surface in 
hemisected brains from P9. (A) hippocampus; (B) cerebellum. (C) 3rd ventricle of an adult 
hypothalamus, dorsal to the ARH; DAPI staining is presented in grey. (D-F) 20X of GFP IHC 
(left, green in merge), direct TOM fluorescence (center, red in merge) and the merged image 
(right) in 10μm sections from adult animals.  (D) cerebellum, (E) DG, (F) NTS.  Scale bars: (A,B) 





FIG. 3.7. Pomc transcript can be detected in the NTS using Neutravidin-amplified ISH. (A,B) AP 
stain of Pomc transcript. (A) ARH; (B) NTS. Abbreviations: 3V, 3rd ventricle; C, central cannal. 








FIG. 3.8. Peptidergic identities of leptin-sensing neurons in the ARH and brainstem. Adult 
Pomc-eGFP ;Pomc-Cre;R26R-TOM animals were injected with leptin (4mg/kg i.p.) following an 
overnight fast.  20X images of GFP IHC (left, green in merged image), P-STAT3 IHC (center-
left, white in merged image), direct TOM fluorescence (center-right, red in merged image), and 
merged image (right) in 10μm sections. Exception (B-left) represents Npy transcript by FISH; 
this technique is combined with IHC for P-STAT3, TOM is detected by direct fluorescence. (A, 
B) ARH. (A) Arrows represent leptin-sensing GFP+ cells, note; in the merged image pink cells 
(red & white) represent leptin sensing non-POMC neurons that are labeled with the TOM 
reporter. (B) Arrows represent leptin-sensing NPY cells that are marked with the TOM reporter. 
(C) PB (D) Brainstem at the level of the AP. Blue arrows indicate leptin-sensing POMC neurons 
in the AP, note; pink arrow represents a leptin-sensing non-POMC neuron that is labeled with 
the TOM reporter. (E) Caudal brainstem. Blue arrows indicate leptin-sensing POMC neurons in 
the NTS. Stereotactic coordinates defined according to Allen Brain Atlas are indicated in the top 
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Abstract 
Neuropeptide products of the pro-protein POMC are processed and released from neurons 
in the hypothalamus. In the mature brain, POMC-derived peptides are relayed to downstream 
targets to influence food intake. In previous studies we have shown that Pomc is expressed at 
high levels in a broad population of hypothalamic precursors during embryogenesis (prior to the 
establishment of circuits regulating food intake). During development, products of POMC 
processing are reported to promote differentiation and specification of neurons and glia in extra-
hypothalamic regions of the brain. We hypothesize that POMC-derived products influence the 
ontogeny of feeding centers in ARH. In these studies we find that both α-MSH and β-EP are 
present during embryogenesis in the MBH and adjacent pituitary anlage. Our current efforts are 
aimed at determining the influence of these POMC-derived peptides on the establishment of the 
ARH. Using a genetic loss-of-function strategy we will assess the composition of the ARH in the 
absence of Pomc (Pomc-GFP;Pomc-/-) and in the absence of β-ep-/- alone. As metabolic 
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baselines are largely determined by orexigenic/anorexigenic tone initiated in the ARH, these 
findings may provide key targets toward altering body weight homeostasis and combating 
obesity. 
Introduction 
Obesity is implicated in the dysregulation of many homeostatic processes that lead to the 
life threatening complications of diabetes, hypertension, and dyslipidemia (Bjorntorp, 1992). 
Despite concerted efforts toward dietary intervention, the prevalence of obesity over the past 40 
years has increased dramatically (Ogden et al., 2010). There is a large body of evidence to 
support the idea that the maternal gestational environment can impart lasting effects on 
metabolic outcomes in offspring. Models of both over- and under- nutrition during pregnancy 
have been shown to program susceptibility for obesity in offspring (Dabelea et al., 2000; Kral et 
al., 2006; Silverman et al., 1998). One hypothesis to explain this aspect of maternal 
programming is that the hypothalamus (a critical determinant of anorexigenic/orexigenic tone) 
develops in response to the hormonal and nutrient environment during gestation. In support of 
this, Simerly et al. (2008) find that obesity-prone offspring reared in an obese gestational 
environment have significantly fewer leptin-sensing cells in the ARH compared to controls 
(Bouret et al., 2008). We hypothesize that nutrient and hormonal signals specific to the obese 
gestational environment can influence the establishment of cellular identity during 
embryogenesis, a consequence that remains intact for the life of the animal. Studies in motor 
neurons find that the establishment of neurotransmitter identity can be biased during sensitive 
periods of differentiation, establishing molecular precedence for our hypothesis in the 
hypothalamus (Root et al., 2008). Terminal fate decisions of neurons in the ARH that mediate 
energy homeostasis are established during embryogenesis. Previous work from our lab 
indicates that functionally opposing anorexigenic POMC and a subset of orexigenic 
neuropeptide-Y/agouti-related peptide (NPY/AgRP) terminal cell fates are derived from a 
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common progenitor. Thus we hypothesize that the signaling events involved in the 
differentiation of these two opposing cell types from a common progenitor establish a basis for 
orexigenic/anorexigenic tone which will determine body weight outcomes, and may explain why 
some individuals, in the face of a Western type diet (characterized by a dietary pattern rich in 
fat, sugar, and red meat, but poor in fiber, fruits and vegetables), are programmed to regulate 
around altered body weight set-points (Fung et al., 2001). 
In previous studies we demonstrated that during embryogenesis, Pomc-expressing 
progenitors give rise to functionally distinct neuronal populations, the minority of which maintain 
a terminal Pomc-expressing cell fate (Padilla SL et al. (2011) manuscript in preparation) 
(Carmody et al., 2010; Padilla et al., 2010). Specifically, we found that during mid-gestation at 
embryonic day (E) 13.5, Pomc is expressed at high levels in most cells of the MBH. From E13.5 
through the end of gestation, Pomc expression is down-regulated in the majority of these cells, 
which subsequently differentiate into non-POMC terminal identities (Padilla et al., 2010). 
POMC is functionally inert as a pro-peptide. Post-translational processing of POMC into the 
functional derivatives of the opioid, β-EP and the melanocortin peptides: adrenocorticotropic 
hormone (ACTH), α-MSH, β-MSH and γ-MSH, occurs in a tissue specific manner (reviewed in: 
(Wardlaw, 2011)). Developmental expression analyses via immunohistochemistry and 
quantitative radioimmunoassays have defined the onset of MC peptides to be one of the earliest 
peptidergic systems in brain. β-EP and ACTH related peptides are, detected as early as E10.5 
in the mouse (Angelogianni et al., 2000; Rius et al., 1991b). Along with this, binding studies 
have shown that both the melanocortin receptors, MC3R and MC4R, and the opioid receptors, µ 
and κ, are not only expressed, but occupied by ligands in the brain during embryogenesis 
(Kistler-Heer et al., 1998; Rius et al., 1991a; Tong et al., 2000). It should be noted that the 
opioid receptor isoforms, µ and κ, are expressed and ligand-occupied as early as E15.5, while 
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the melanocortin receptors, MC3R and MC4R, are induced later, first detected at E18.5 in the 
MBH (Rius et al., 1991b).  
During embryogenesis, in vivo studies support that opioid ligands, including β-EP, are 
involved in stimulating neurite outgrowth from neurons in the sympathetic ganglia and spinal 
cord, and also stimulates proliferation cells of the retina (Ilyinsky et al., 1987; Isayama et al., 
1991 ). MSH variants including α-MSH have also been shown to be involved in neurite 
outgrowth in retinal ganglion cells (Lindqvist et al., 2003). In vitro studies further support that 
both β-EP and ACTH related peptides can act as trophic factors and are involved in 
specification of both neurons and astrocytes (Cossu et al., 1989; Eriksson et al., 1991; Hauser 
et al., 1996; Satoh and Ide, 1987; Vernadakis and Kentroti, 1990). Together, this work supports 
a role for POMC-derived peptides, prior to circuit formation, in the differentiation and 
specification of cell types. In the mature brain, hypothalamic derived α-MSH signaling is relayed 
via axonal projections to distant melanocortin receptors, eliciting an anorexigenic effect with 
respect to food intake and energy expenditure (Campfield et al., 1995; Fan et al., 1997; Huszar 
et al., 1997; Yaswen et al., 1999). Neurite outgrowth from neurons in the ARH occurs during 
perinatal development, while mature projection patterns from the ARH are achieved by 
postnatal day (P) 18 (Bouret et al., 2004). Because we identify high levels of Pomc expression 
in the MBH during embryogenesis, prior to circuit formation, and because POMC-derived 
peptides have been shown to participate in differentiation and specification of neurons and glia 
in extra-hypothalamic regions of the brain, we hypothesize that POMC-derived peptides 
participate in early developmental events. In this study we will characterize the temporal profile 
of POMC-derived peptides in the MBH and will also examine the effects of these products on 
differentiation and cell fate decisions in the mature ARH. 
Recent data supports the idea that Ngn3 is involved in the differentiation of the Pomc 
lineage. Using a genetically null Ngn3 mouse model, Pelling et al, describe a diminished 
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number of POMC neurons concomitant with an expansion of both NPY and TH+ cells, such that 
the total number of ARH neurons was the same (Pelling et al., 2010). This study exemplifies 
that disruptions during differentiation can affect cell fate choices, which ultimately alter cellular 
composition of the ARH. We hypothesize that POMC signaling, like Ngn3, will impact the 
differentiation of cells in the ARH and determine the cellular composition in these offspring.  
Results 
Ontogeny of POMC-derived Processing Products and Receptors 
Because POMC-derived peptides can influence differentiation and specification of extra-
hypothalamic cells, and given that Pomc is expressed at high levels during embryogenesis in 
the presumptive MBH, we first developed a strategy to quantify POMC-derived peptides in the 
MBH across gestation and early postnatal development. In the literature, studies have 
attempted to quantify products of POMC processing in the MBH during embryogenesis (Kistler-
Heer et al., 1998; Rius et al., 1991b). However, Pomc is expressed at high levels in both the 
hypothalamus and adjacent anterior pituitary during embryogenesis (Padilla et al., 2010; Poulin 
et al., 1997), therefore, it is possible that previously analyzed hypothalamic tissue may have 
contained Pomc-expressing pituitary cells. In this study we have developed a strategy to visually 
define the hypothalamic/pituitary border using a fluorescent reporter driven off the regulatory 
elements of Pomc (Pomc-GFP). This fluorescent marker provides a means to define the 
hypothalamic/pituitary border, allowing for precise dissection of each region by fluorescent 
microscopy of whole mount embryos (Figure 4.1) (Cowley et al., 2001).  
Hypothalamic and pituitary isolates were analyzed by radioimmunoassay (RIA) for α-MSH 
and β-EP. In preliminary studies, we observed β-EP protein in the hypothalamus as early as 
E13.5, but first detected small amounts of αMSH at E16.5 (table 4.1). Efforts to increase 
numbers and time-points are necessary to achieve statistical significance are underway. We will 
perform repeated measures at each stage (n≥3 for each stage analyzed), and also expand this 
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data set to include E11.5–E18.5 for β-EP, E15.5–E18.5 for α-MSH, also including a complete 
workup from E11.5-E18.5, P9 for ACTH.  
These RIA quantification studies will provide a timeline of ligand presence and, in 
conjunction with similar studies using PCR and IHC for ligand receptors, will serve as the 
foundation to investigate the role of POMC-derived proteins in differentiation and cell fate 
determination in ARH neurons. Our data indicating the early detection of β-EP at E13.5 are 
consistent with literature investigating the onset of opioid system activity in the embryo (Rius et 
al., 1991b). We determined the expression of one relevant opioid receptor, µ-opioid receptor 
(MOR), by IHC. Preliminary stains demonstrate a dynamic profile of MOR distribution at: E13.5, 
E18.5 and in the mature ARH. At E13.5 the staining of MOR appeared to mark narrow fiber-like 
cells throughout the mantle layer of the ventral hypothalamus and in the proliferating verntricular 
zone (3V). We did not detect MOR-IR in the MBH at E18.5 (positive staining was identified in 
the habenular region of the thalamus (data not shown)). In the adult, MOR staining distinctly 
labeled cell bodies in the ARH and medial VMH (Fig. 4.2). Additional IHC and PCR studies are 
underway to confirm these findings. Also, we are working to determine the identity of E13.5 





Composition of Neuronal Cell Fates in the ARH 
Using a loss-of-function model, we will investigate the effects of POMC and β-EP on the 
development and establishment of cell populations in the ARH. To facilitate these analyses, we 
characterized the composition and relationships of the known terminal cell fates in the ARH. 
Using fluorescent in-situ hybridization (FISH) we characterized the quantity and distribution of: 
Pomc, neuropeptide-Y/agouti-related protein (Npy/Agrp), cocaine-amphetamine related 
transcript (Cart), tyrosine hydroxylase (Th), growth hormone related hormone (Ghrh), 
gonadotropin-releasing hormone (Gnrh), somatostatin (Sst), kisspeptin (Kiss) and galenin (Gal) 
expressing cells in the ARH (Figure 4.3, Table 4.2). Kiss is not included in Table 4.2 because it 
is expressed at low levels and can only be identified by single process colorimetric ISH. The 
numbers and distribution patterns found in this data set provide a foundation for which 
evaluating the influence of POMC processing products on the differentiation of terminal cell 
fates in the ARH.  
Table 4.1 
Table 4.1. POMC-derived peptides, α-MSH and β-EP are expressed in the hypothalamus 
and pituitary during embryogenesis. Quantitative analysis of: unprocessed POMC by ELISA 
and α-MSH and β-EP by RIA in tissue extracts of Pomc-GFP transgenic animals. Note: 
E13.5, 15.5, 18.5, P9 (n=1); E14.5 (n=2). **, has not been analyzed; ‡, sample recording 




Developmental Consequences of POMC Loss-of-function 
To investigate the roles of POMC-derived products in the differentiation of cell types in the 
MBH, we will utilize two genetic loss-of-function models targeted to the Pomc locus. We have 
begun to analyze the neuronal phenotypes in the global Pomc-/- null animal. To facilitate the 
visualization of  -expressing neurons in the absence of POMC transcript, we crossed both both 
Pomc-/- and β-Ep-/- null animals to a Pomc-GFP reporter. In a preliminary analysis, we found a 
nearly three-fold expansion of GFP+ cells in Pomc-/-; Pomc-GFP animals versus controls (Fig. 
4.4) (GFP-KO: 57±7, GFP-WT: 24±2) .  
We have obtained β-Ep-/- null tissue from Malcolm Low and will track the fate of POMC cells 
using ACTH-IR (Rubinstein et al., 1996)  
Working Hypotheses and Future Studies 
POMC-derived peptides have been shown to play a role in the differentiation and 
specification of both neuronal and glial cell fates in the retina and spinal cord (Cossu et al., 
1989; Eriksson et al., 1991; Hauser et al., 1996; Ilyinsky et al., 1987; Isayama et al., 1991; 
Lindqvist et al., 2003; Satoh and Ide, 1987; Vernadakis and Kentroti, 1990). In the ARH, 
Table 4.2. Comparative analysis of distinct terminal cell fates in the ARH. Double 
expression analysis was evaluated and overlapping expression patterns are notated as a 
percentage of row/column. Deviation is calculated as standard error. Grey boxes; 




differentiation and acquisition of terminal fate identity occurs during embryogenesis, while 
axonal outgrowth and synaptic connectivity are established in the perinatal period (Bouret et al., 
2004; Markakis, 2002; Shimada and Nakamura, 1973). In previous work we established that 
Pomc is expressed in most cells of the presumptive ARH at E13.5 and is subsequently down-
regulated in the majority of these early progenitors, as the lineage differentiates into distinct 
terminal identities. In this work we detect immunoreactivity of both β-EP and MOR in the 
hypothalamus at E13.5 (Table 4.1, Fig. 4.2), and anticipate that this opioid system will influence 
the differentiation of hypothalamic cells.  
Using a combination genetic ablation/reporter strategy (Pomc-/-; Pomc-GFP), we have begun 
to investigate the influence of POMC-derived proteins on cell fate decisions in the ARH. 
Primarily we find that Pomc expression is not imperative for cellular survival, as we detect GFP+ 
cells in Pomc-/-; Pomc-GFP tissue (GFP-KO). Next, we demonstrate that GFP-KO cell numbers 
are approximately 3 times that of Pomc-GFP+ cells on a wild-type background (GFP-WT). 
Considering that the relative area of the ARH is not changed in the null mutant compared to 
wild-type, we anticipate compensatory alterations in the composition of terminal cell fates in the 
Pomc-/- ARH.  
The distribution and number of GFP-KO cells are comparable to those detected in Pomc 
lineage tracing assays (Fig. 4.5) (Padilla et al., 2010). One hypothesis to explain this outcome, 
is that β-EP acts on Pomc-expressing progenitors at E13.5 to direct the differentiation of non-
POMC terminal fates. In the absence of this signaling molecule, the Pomc-derived lineage may 
be held in an immature state. To confirm this hypothesis we will need to verify an immature 
neuronal marker that is present in the immature Pomc-expressing population at E13. One 
potential marker of this population is Doublecortin (DCX), a marker of immature neurons, that is 
present in the presumptive ARH at E13.5 (Lein et al., 2007). If DCX overlaps a significant 
population of Pomc-expressing cells at E13, then we will perform double IHC/FISH (DCX/Pomc) 
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at E13.5 and will then evaluate DCX relative to the mature GFP KO population by IHC. If DCX 
co-localizes with all GFP-KO cells in the adult, then we will assume that these cells have not 
differentiated into a terminal fate and would expect this to come at the consequence of obtaining 
markers of a terminal identity. In this case, we would expect to find a decrease in the number of 
NPY/AgRP neurons, as a subset of this population is derived from a Pomc-expressing lineage. 
It is also possible that the Pomc-expressing lineage differentiates into terminal cell fates, but 
does not inhibit the regulatory elements driving Pomc-transcriptional activity upon differentiation. 
In this case we would expect to see an increase in non-POMC terminal fates derived from a 
Pomc-expressing lineage (X-POMCs), compensatory to the loss of POMC neurons. This may 
be reflected in higher NPY numbers, however, approximately 30 percent of the XPOMC 
population are yet undefined and therefore an increase in these “other” X-POMCs cannot be 
ruled out in the absence of an NPY phenotype. 
While our data supports that POMC-derived proteins influence Pomc-expressing lineage, it 
is also possible that these products influence the differentiation of neighboring cell fates via local 
diffusion. Using a lineage tracing strategy, we have determined that Sst, Gal, and Ghrh-
expressing cells are independent of the Pomc-expressing lineage (data not shown). In future 
studies we will quantify and compare the composition of these terminal cell fates in Pomc-/- 
tissue, compared to Table 4.2.  
In vitro studies support that POMC processing products are required for the differentiation of 
ACTH- and α-MSH-expressing terminal fates and also that opiod peptides, namely β-EP, can 
inhibit Pomc transcription (Daikoku et al., 1983; Hermesz et al., 2003; l'Hereault and Barden, 
1991). Consistent with this idea, our data support that β-EP is involved in the down-regulation of 
Pomc transcript. To strengthen this argument we will perform IHC for ACTH on β-Ep-/- null 
embryonic tissue compared to controls (characterizing tissue from E13.5 through E18.5). 
Because the β-Ep-/- specific mutation does not disrupt POMC processing to ACTH/related 
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products, we can use this expression profile to investigate the effects of β-EP on Pomc activity. 
Furthermore, in previous work we have determined cell counts for Npy in the MBH across 
embryogenesis. We will evaluate this expression profile in Pomc-/- and β-Ep-/- null animals to get 
a broad sense of the contribution of α-MSH versus β-EP on differentiation decisions. 
In conclusion, we have established a system and developed tools to investigate the 
influence of POMC-derived peptides on the differentiation of cells in the ARH. Our data so far 
are consistent with the hypothesis  that β-EP influences developmental decisions of Pomc-
expressing progenitors. In previous studies we have defined that Pomc-expressing progenitors 
differentiate into numerous distinct cell types, two of which are thought to mediate opposing 
roles in food intake and energy expenditure. Furthermore, we also detect the presence of α-
MSH at E15.5, a time in which many terminal identities, including Npy, are obtained in the ARH. 
Finally, both α-MSH and β-EP are implicated in stimulating axonal outgrowth and are in the 
perinatal ARH when axonal outgrowth occurs. While further experiments are needed, we 
believe that POMC-derived peptides are critical to the differentiation and specification of cells 
that determine food intake and energy expenditure in the ARH. Future prospect of this work may 







Fig. 4.1. Discrete hypothalamic and pituitary dissections of Pomc-GFP reporter tissue at E13.5. 
(A-C) Whole mount hemisection from the ventricular surface (magnification 1.6X). (A) prior to 
dissection; (B) post hypothalamic dissection; and (C) following pituitary dissection. All images 
are presented rostral, right. (B,C) zoom boxes in the top right contain images of the dissected 
tissue (B) hypothalamus; (C) pituitary. 
 





Fig. 4.3. MOR is dynamically expressed during embryogenesis and is subsequently up-
regulated in the mature state. MOR-IR performed on wilt-type tissue at: E13.5 (Left), E18.5 
(Center) and in the Adult (right). Scale bar: 100 µM; tissue 10 µm cryo-sections; 3V, third 






Fig. 4.3. Relative numbers of distinct terminal cell fates in the ARH. We used FISH to define 
cells in the ARH that expressed Npy, Pomc, Sst, Gal, Cart, Ghrh and Kiss. TH was detected by 
IHC. Single cell counts were qualified by co-locolization with the nuclear marker DAPI. Each 
group represents the average counts of at least five coronal sections per mouse, spanning the 







Fig. 4.4. Pomc-expression is not required for the survival of POMC neurons; in the absence of 
Pomc transcript, there is an expansion of the Pomc-GFP+ population. (A,B) Histologocial 
analysis of Pomc-GFP (left) versus Pomc-/-;Pomc-GFP (right) tissue. (A) Endogenous GFP 
expression. (B) Pomc expression by FISH. (C) Quantitation of cell numbers (by FISH or 
endogenous GFP) per ARH hemi-section, averaged across the rostral-caudal extent of the 
ARH. Scale bar, 100um; error bars calculated as standard deviation; cell counts: Pomc (n=20); 








Animals were housed in temperature controlled rooms at 21 °C and subject to a 12 h light-
dark cycle. Mice had ad libitum access to standard chow diet (Lab Diet: PicoLab Rodent Diet 
5053) and water. C57BL/6 mice  were obtained from the Jackson Laboratory and bred at the 
Russ Berrie Animal Facility. Pomc-GFP (Cowley et al., 2001) transgenic animals were 
generously provided by Malcolm Low. All procedures were performed in accordance with the 
guidelines of the Institutional Animal Care and Use Committee at the Columbia University 
Health Sciences Division. 
Genotyping 
Genotyping for GFP was performed using primer set: 
Gfp-F 5’-AAGTTC ATCTGCACCACCG-3’ 
Gfp-R 5’-TCCTTGAAGAAGATGGTGCG-3’   
Fluorescent In Situ Hybridization 
Tissue Processing: FISH: Adult mice were anesthetized and perfused transcardially with 
0.9% NaCl followed by 4% paraformaldehyde (PFA) in phosphate buffer (PB). Brains were post-
fixed at 4°C overnight and cryoprotected with 30% sucrose for 48 h. For embryonic tissue, dams 
were anesthetized with Avertin and embryos were dissected in cold PBS and fixed at 4 °C 
overnight and cryoprotected with 30% sucrose for 24 h. Tissue was embedded in O.C.T (Tissue 
Tek) and frozen at –80°C. 10 µm-thick coronal sections were collected across the rostral–
caudal extent of the ARH on Superfrost Plus slides (Fisher).  
FISH: Frozen sections were processed as described in the TSA Plus Cy3 System manual 
(Perkin Elmer).  Antisense digoxigenin-labeled riboprobes were generated for: Npy, Pomc,Th, 



















Imaging and Quantification 
Fluorescent microscopy was performed using a Nikon Eclipse 80i equipped with a Retiga 
EXi camera and X cite 120 fluorescent illumination system. TIFF files were acquired using Q 
Capture Pro software (Qimaging) and analyzed using Adobe Photoshop. We used a diamidino-
2-phenylindole (DAPI) stain to establish a reference focal plane. Images were separated into 
independent RGB channels using Photoshop, and fluorescent signals were compared relative to 
DAPI (as described in (Padilla et al., 2010)).  
GFP fluorescence is lost during the high temperature hybridization step; thus, we pre-
imaged direct GFP fluorescence in conjunction with DAPI. Following FISH, the tissue was re-
stained with DAPI and imaged. Using Photoshop, pre- and post-FISH images were aligned 
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using the common DAPI stain as a reference to generate a composite image (as described in 
(Padilla et al., 2010)).  
Immunohistochemistry (IHC) 
Fixed slide-mounted sections were blocked in 2% normal horse serum; 0.1% Triton X-100 
(Block Buffer) at room temperature.  Primary antibody incubation was performed using either 
mouse anti-TH (1:1000; Chemicon MAB318) or rabbit anti-MOR (1:4000; AbCam ab10275) at 4 
°C overnight.  Tissue was then washed in PBS and incubated in with secondary using either 
goat anti-guinea pig Alexa-488 (1;500 invitrogen) or goat anti-rabbit cy5 (1;100 invitrogen), for 
one hour at room temperature.  
Radioimmunoassay (RIA) 
Tissue was extracted into 0.1N HCL at 4deg C, homogenized via sonication and the 4K X g 
supernatant was used for quantitative RIA analysis. Pomc-GFP+ embryos from each litter were 
pooled for RIA analysis. β-EP and α-MSH antibodies were generated in the Wardlaw laboratory 
(Jaffe et al., 1994).  
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Chapter 5: Concluding Remarks 
Neuronal determinants of body weight have largely been investigated in mature organisms 
with relatively little focus on the developmental establishment of the circuits and signals which 
mediate this output. While mounting evidence from epidemiological studies support that 
environmental factors present during development can influence the body weight outcome in 
individuals (reviewed in: (Grattan, 2008)), little is known regarding the differentiation of cells that 
mediate metabolic homeostasis. Our studies, focused on defining the ontogeny of two 
populations in the ARH – orexigenic NPY/AgRP and anorexigenic POMC neurons – that have 
been described to inversely modulate energy homeostasis. Unexpectedly, we found that Pomc 
was expressed in the majority of cells of the mediobasal hypothalamus during mid-gestation and 
was subsequently down-regulated during later stages of development. Using a genetic tracing 
technique (Pomc-Cre;R26R-reporter), we went on to show that in the ARH, along with other 
regions of the brain, Pomc is transiently expressed in many immature cells which ultimately 
differentiate into non-POMC terminal identities, some of which include NPY/AgRP neurons in 
the ARH.  
These preliminary findings raise the possibility that developmental events can influence cell 
fate decisions in the hypothalamus. For example, if the immature Pomc-expressing population is 
homogeneous and gives rise to numerous cell fates based in extrinsic signaling factors, then it 
is possible that environmental factors present during gestation may influence the composition of 
many cell fates throughout the brain (cells derived from Pomc-expressing precursors). Because 
we find that both POMC and a subset of NPY/AgRP neurons contain the Pomc-Cre reporter 
signal, it is possible that both populations are derived from an immature Pomc-expressing 
precursor. In this case, it is intriguing to consider that this node of differentiation may be 
vulnerable to environmental factors during development, and as such, immature Pomc-
expressing cells may provide a target to further investigate the mechanisms by which maternal 
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factors during gestation can influence cell fate decisions. While these preliminary findings are 
intriguing and have been at the forefront of discussion in the field, reviewed as a “must read” by 
the Faculty of 1000, this work is only the beginning of our lab’s efforts to define the 
differentiation of ARH populations. Important to the interpretation of our results thus far, is 
whether immature Pomc-expressing cells are homogeneous, or if Pomc is transiently expressed 
in many lineages (representative models presented in Figure 5.1) 
 
ARH lineages: transcription factor screen 
Our data in Appendix A support that POMC neurons in the ARH share a common lineage 
with other ARH cell types – potentially including NPY/AgRP. In this study, we performed a 
screen for lineage markers of NPY and POMC neurons in the ARH. Of 29  transcription factor 
candidates, none mapped exclusively to either Pomc- or Npy-expressing cells (Table A.1). 
Instead, the candidate lineage markers mapped to either all POMC/NPY cells plus other ARH 
cells, or were present in a subset of POMC/NPY cells plus other ARH cells. For instance, within 
POMC neurons, the transcription factors: Tbx3, Peg3, Otp and Fto were present in all POMC 
neurons along with other cell types in the ARH. These data are consistent with model A, a 
Fig. 5.1. Modeling Pomc progenitor Specification. Abbreviations: NEP, neural epithelial 
progenitor; NP, NPY neurons derived from a Pomc progenitor; NX, NPY neurons derived from 




scenario in which POMC neurons are derived from a multipotent immature precursor which 
differentiates into numerous terminal fates, including POMC. 
In addition, we found that the candidate lineage markers: Dlx6, Elk1, Er81, Lhx9, Lrrn3, 
Nhlh2 and Tbx19 were co-expressed in a subset of POMC neurons along with other cell types 
in the ARH. Candidate markers present in subsets of POMC plus other ARH cells, raise the 
possibility that more than one progenitor cell type gives rise to a POMC terminal fate, as 
depicted in model B; however, this data also supports our findings above, that immature 
neurons of a POMC lineage are multipotent. Unlike the candidate lineage model discussed 
previously, in this model, a multipotent immature neuron differentiates into a limited subset of 
POMC neurons plus other cell types in the ARH.  
Based on our lineage screen and Pomc-Cre reporter studies, we hypothesized that some 
NPY/AgRP neurons may be derived from a common progenitor as a subset of POMC neurons 
(Table A.1, Fig. 2.2). This concept of a common progenitor giving rise to numerous ARH cell 
types, some of which may be functionally opposing, lends to the potential that environmental 
factors during development can bias differentiation events and may influence the anorexigenic 
tone in the ARH. It is important to note that our candidate transcription factor screen was 
performed at P7 and validated in the mature ARH. We have yet to map our lineage candidates 
in the embryo, and therefore cannot conclude on how these markers relate to early Pomc- or 
Npy-expressing populations. To further elucidate the diagram of POMC lineages, our future 
studies will evaluate our candidate markers relative to Pomc and Npy across development. 
Timing 
In order to examine how cell fate decisions may influence the physiological outcomes in 
mature organisms, it is important to define the timing and signaling factors involved in these 
processes. As a first step, we performed stereological corrections on our previous analysis of 
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Pomc-expressing cells during embryogenesis to identify critical temporal periods of 
development in which Pomc is transcriptionally down-regulated. 
Since the publication of our data in Chapter 2, we have investigated the stereology of the 
mediobasal hypothalamus during embryogenesis, finding that the area of the presumptive ARH 
undergoes a general expansion between E14.5 and E15.5, and subsequently remains constant 
through birth (stereologically corrected counts: Fig. 5.3). Upon correction, the largest decline in 
the number of Pomc-expressing cells occurs between E13.5 and E14.5, with another smaller 
decline in cell number between E17.5 and E18.5 (Fig. 5.2 A). These two time windows during 
embryogenesis represent changes in the differentiation of immature Pomc-expressing neurons; 
however, it is also important to consider that numerous lineages may contain an early transient 
Pomc-expressing state, and also that changes may occur independent to the dramatic changes 
in Pomc transcription.  
 
Terminal cell fates in the ARH 
In Chapter 2 we demonstrated that the majority of both POMC and NPY/AgRP exit mitosis 
between E11-E12 (Fig. 2.1). We also determined that the number of Npy- and Pomc- 
Figure 5.2 
Fig. 5.2 Pomc-expressing cell count during embryogenesis with stereologic correction. The 
total area of the ARH undergoes a 22 percent expansion at E15. Cell numbers prior to this 
stage have been corrected, represented as 22 percent less than the original counts. Pomc-




expressing cells at E18 was similar to that of the adult. This data may indicate that 
differentiation events of these cell types occur during the last week of gestation, however, it is 
important to consider that many terminal markers indicative of these terminal cell fates are not 
expressed until postnatal stages including: Agrp, Cart and letpin induced PSTAT3 (Ahima et al., 
1998; Cottrell et al., 2009; Nilsson et al., 2005). Given this, differentiation of immature cells may 
also be susceptible to bias during the acquisition of a terminal fate in the postnatal period.  
Numerous studies in the recent literature indicate that POMC neurons in the ARH are not 
homogenous. These studies determined heterogeneity among mature POMC neurons in an 
electorphysiologic response with respect to: leptin, insulin, glucose and also within expression of 
GABA and glutamate (Hentges et al., 2009; Ibrahim et al., 2003; Munzberg et al., 2003; Parton 
et al., 2007; Williams et al., 2010). In conjunction with this, we have determined that Cart is 
expressed in a subset of POMC neurons (Fig 5.2). These findings support that mature Pomc-
expressing neurons are not homogeneous in function. In future studies we will map markers of 
these functional subsets to our lineage candidates to further elucidate terminal characteristics of 






Fig. 5.3. Cart is expressed in a subset of POMC neurons. Representative ARH from 
Pomc-GFP reporter transgenic evaluated for Cart by FISH (red). Arrows indicate 
double positive GFP/Cart cells. 
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Progenitor fate: exogenous factors biasing orexigenic tone 
Recent data in the literature demonstrate that the maternal environment can influence the 
differentiation of Pomc progenitors, a consequence that may impart body weight outcomes in 
exposed offspring. Below are three examples highlighting composition changes in the ARH at 
various stages of development when exposed to a particular maternal environment. These 
studies further allude to critical time windows and also implicate candidate signaling factors 
involved in the differentiation of ARH lineages, implicating candidate extrinsic signaling factors 
that may influence the developing: progenitor population, early differentiating cells and also the 
later stages of acquiring a terminal cell fate in the ARH. 
Unpublished research from the Bouret lab has demonstrated that the maternal environment 
can influence progenitor proliferation in the mediobasal hypothalamus, a consequence which 
correlates to an alteration in the composition of cells in the mature ARH. Specifically, they 
determined that developing ob/ob animals, lacking intrinsic leptin, have increased cellular 
proliferation during embryogenesis and also found that these animals have statistically more 
NPY/AgRP and concomitantly less POMC neurons in the mature ARH (personal communication 
of unpublished data). Because ob/ob animals are largely infertile, these offspring were bred 
from pairs of heterozygous (ob/+) parents. Dams heterozygous at the leptin allele have: slightly 
more body fat, are hypoleptinemic relative to adiposity, are hyperglycemic and also 
hyperinsulimenic (Chung et al., 1998; Flatt and Bailey, 1981). Given this, it is possible that the 
altered nutrient and hormonal factors present in ob/+ dams during gestation and lactation 
influence the differentiation of hypothalamic progenitors.  
In addition to this work, Pelling et al. (2010) investigated the fate of Ngn3 descendent cell 
types in the ARH and found that the expression of this transcription factor can influence the 
composition of postmitotic cells during embryogenesis. They demonstrated that Ngn3 null 
animals (Ngn3-/-) had a reduced number of Pomc-expressing cells during embryogenesis (E10- 
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E17), accompanied by compensatory expansion of NPY and TH immunoreactive (IR) cells 
(Pelling et al., 2010). Because the number of NPY and TH IR cells was directly proportional to 
the loss of Pomc+ cells, it is possible that these cell types share a common Ngn3+ progenitor.  
This study supports the idea that multiple progenitors give rise to postmitotic Pomc-
expressing cell types of the hypothalamic parenchyma. Pelling et al. detect a reduction in only a 
subset of Pomc-expressing cells, suggesting that only a subset of the population is derived from 
an Ngn3+ progenitor. Furthermore, using an Ngn3-Cre reporter strategy, that determined that at 
E10 nearly all Pomc-expressing progenitor cells in the ventricular zone co-expressed the Ngn3-
Cre reporter, while at E15 the reporter was only present in a subset of cells. This data supports 
the idea that non-Pomc-expressing progenitors can give rise to postmitotic cells which later 
obtain a Pomc transcriptional identity, further supporting the idea that Pomc is not a lineage 
marker, but rather, is transiently expressed in numerous hypothalamic lineages throughout 
development. The Ngn3-Cre reporter was also detected in a subset of Npy-expressing cells at 
E15. Given the proportional changes in Npy-expressing cell counts in the absence of Ngn3, and 
also given that we detected Pomc-Cre reporter in a subset of NPY/AgRP neurons, it is possible 
that some Pomc-expressing Ngn3+ cells in the ventricular zone at E10 differentiate into an Npy-
expressing fate.  
Due to perinatal lethality, the consequences of a loss of Ngn3 on the ultimate composition of 
the ARH and its effects on energy homeostasis were not achieved. Unfortunately, this study 
was also terminated prior to the acquisition of terminal functional capacity (e.g. leptin sensing 
and/or Cart expression) and therefore does not specifically address the impact of Ngn3 on 
mature POMC neurons. Considering the transient and likely multipotent nature of Pomc 
expressing cells during embryogenesis, it is possible that the early loss of Pomc+ cells in the 
absence of Ngn3 will not predict the outcome of mature POMC neurons. In the future it would 
be interesting to conditionally target an Ngn3 knock-out to the hypothalamus using Nkx2.1-Cre 
125 
 
(hypothalamic specific, (Xu et al., 2008)) crossed to Ngn3fl/fl. Because the perinatal lethality due 
the global loss of Ngn3 is likely due to misspecification of pancreatic progenitors (Apelqvist et 
al., 1999), this proposed hypothalamic specific deletion will likely result in viable animals, 
providing a means to evaluate the consequent composition of terminal fates in the ARH, along 
with evaluating the body composition phenotype in the absence of Ngn3 in the hypothalamus. 
Finally, in a model of maternal hyperinsulinemia, JS Carmody et al. (2010) investigated the 
ontogeny of hypothalamic cell fates and determined that the maternal environment can 
influence the acquisition of terminal cell fates in offspring. In this study, they identified more 
Pomc+ cells at P0, which reached statistical significance at P9. No changes were detected in 
the number of Pomc or Npy+ cells at E14 – a candidate phase of Pomc progenitor 
differentiation (Carmody et al., 2010). In conjunction with fewer Pomc+ cells in the postnatal 
period, there was a compensatory trend toward more Npy+ cells. This trend did not reach 
statistical significance in this study, however considering the possibility that that the increase in 
Npy+ cells occured in direct proportion to the decrease in Pomc+ counts, and that the number of 
Npy+ cells in the ARH is nearly double that of POMC neurons, this trend would not achieve 
significance within the number of animals tested in this study. This data supports the idea that 
maternal insulin may influence differentiation during later stages of gestation, but does not have 
an effect prior to E14. In conclusion, Carmody et al. argued that developmental alterations in the 
Pomc-expressing population during perinatal development provided adaptive response to the 
nutrient enriched environment, protecting the offspring from alterations in body weight, because 
unlike maternal obesity, isolated hyperinsulinemia did not confer a body weight phenotype in 
exposed offspring. This study did not consider the heterogeneity among POMC neurons, but it 
is also possible that composition of functional POMC subsets (introduced earlier in this 




POMC during development: 
In the adult, POMC signaling is an integral component of circuits that mediate energy 
expenditure; however in the embryo, POMC signaling is thought to play a trophic role. During 
development, opioids, including β-endorphin (β-EP) and adrenocorticotropic hormone (ACTH) 
derived peptides, including α-melanocyte stimulating hormone (α-MSH), can influence the 
differentiation and specification of both neuronal and glial identity in aspects of the retina and 
spinal cord (Cossu et al., 1989; Eriksson et al., 1991; Hauser et al., 1996; Ilyinsky et al., 1987; 
Isayama et al., 1991; Lindqvist et al., 2003; Satoh and Ide, 1987; Vernadakis and Kentroti, 
1990). Considering that most terminal cell fate decisions in the ARH are determined during 
embryogenesis, and also that high levels of Pomc transcript are present in the presumptive 
ARH during mid-gestation (Fig. 2.1 d,f), we hypothesized that POMC-derived protein was 
involved in the acquisition of terminal cell fates in the hypothalamus. In a preliminary data set 
we detected both β-EP and α-MSH in the MBH during embryogenesis (Table 4.1). Furthermore, 
using a genetic loss-of-function allele (Pomc-/-) crossed to a transgenic reporter (Pomc-GFP), 
we determined first, that Pomc transcription was not necessary for the survival of this cell 
population, and second, that POMC-derived protein can dramatically influence differentiation 
amongst the Pomc-expressing lineage (Fig. 4.4). In the absence of POMC-derived protein, the 
Pomc-GFP population expanded 3-fold in cell count, a change that was not accompanied by a 
significant alteration in cell number or area of the ARH. We are currently working to further 
define the compensatory changes which account for the missing POMC neurons and also are 
working to determine the distinct POMC-derived processing products involved in these 
differentiation events. The details of these efforts are described in chapter 4: “Working 




Given the above arguments, it is likely that some NPY neurons are derived from a Pomc 
precursor and may also share a common lineage with some or all POMC neurons. We detected 
Pomc-Cre mediated reporter expression in a subset of ARH NPY neurons and have 
subsequently characterized that this Pomc derived NPY (NPYP) subset also expresses markers 
involved in orexigenic signaling including: Agrp and Gad65/67. Distinctions within the NPYP may 
involve projection patterns and/or the expression of alternative functional genes. In order to 
define molecular markers to distinguish NPYP we will use a micro-array strategy of FACS 
purified fluorescent cells from: Npy-GFP;Pomc-CRE;R26R-TOM and Pomc-GFP. Npy-
GFP;Pomc-CRE;R26R-TOM bisgenic tissue will provide a means to isolate NPY neurons 
[GFP+] from NPYP [GFP+/TOM+]. Micro array analysis of extracted RNA from these isolates 
should indicate the intrinsic differences between NPYP versus NPYX providing markers to 
further investigate the physiologic contribution of these subsets. Within these studies we will 
also collect the TOM alone fraction, representing non-NPY cells derived from a Pomc lineage in 
the MBH. We expect this fraction to contain both POMC neurons and also the ‘other’ yet 
undefined X-POMC populations. To obtain molecular distinction of X-POMCs from POMC 
neurons, we will compare the isolated TOM+ population to GFP+ cells collected from Pomc-
GFP transgenic animals at the same age. Efforts are currently underway to collect these FACS 
isolates for the prospective comparative microarrays. It is important to note that neurite 
outgrowth from the soma prevents successful dissociation of live cells in primary culture. To 
avoid this, the studies mentioned above are performed at P9, a developmental state which is 
indicative of the mature neuronal profile, yet prior to axonal outgrowth. Our data from these 
arrays should help to determine: molecular markers for the subset NPYP neurons, distinguish 
functional markers and neurotransmitter profile in the yet undefined X-POMC population and 
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also to determine the degree to which NPYP and NPYX are related along with the relationship 
between Pomc-GFP and X-POMC neurons.  
Conclusion 
In this discussion POMC signaling has been demonstrated to play a distinct functional role 
depending on maturation state of the cell. In the mature ARH POMC neurons produce the 
anorexigenic neuropeptide αMSH, which when transmitted to downstream MC circuits regulate 
appetite and energy expenditure. During development however, POMC processing products 
have been demonstrated to act as trophic factors. Our preliminary studies are consistent with 
the model that there is heterogeneity among progenitors that give rise to Pomc-expressing cells 
in the embryo and in the adult. While our data support that a common multipotent immature cell 
likely gives rise to numerous cell types in the ARH, some of which may be functionally opposing, 
we believe that it is unlikely that Pomc expression during embryogenesis is restricted to one 
specific lineage. In this case, Pomc expression in immature neurons likely acts as a 
differentiation signal to certain regions of the brain (Table 3.1), and not as a bona fide lineage 
marker for POMC neurons.  
Ongoing studies in the lab are aimed at developing new tools to investigate lineages in the 
ARH, and to characterize critical time windows for differentiation events. We have mapped both 
candidate lineage markers and also functional markers relative to POMC and NPY in the ARH 
(Table A.1 and 4.2). Sorting studies outlined above will likely identify additional markers. Each 
candidate marker will need to be validated based on expression pattern of the transcript of 
interest in both the embryo and in the mature ARH. Co-expression analysis will then be 
performed relative to POMC, NPY/AgRP and leptin-sensing neurons in the adult. 
Consistent with previously published reports, we find that following a fast challenge and IP 
leptin bolus, PSTAT3 (an indicator of leptin signal transduction) immunoreactivity is co-
expressed in subsets of NPY/AgRP and POMC neurons, along with marking other cell in the 
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ARH (Fig. 5.4 A) (Cowley et al., 2001; Hill et al., 2010). Many of our candidate lineage marker 
expression profiles demonstrate a similar distribution; namely: Dlx6, Elk1, Lhx9, Nhlh2 and 
Tbx19. While we have not yet evaluated these markers relative to the PSTAT3 population, there 
is a possibility that the leptin sensing ARH terminal cell fate arises from a common lineage. 
Given that the profile of PSTAT3 matches many of our lineage candidates, is possible that the 
leptin sensing terminal fate in the ARH is derived from a common lineage; fitting the model that 
subsets of POMC and NPY/AgRP have a common progenitor (Fig 5.4 B). 
There is evidence in the literature to support that the maternal nutrient environment can 
influence the ontogeny of leptin-sensing cells in the ARH. Polygenetic DIO animals are 
predisposed to obesity when exposed to a HFD (Levin et al., 1997). Offspring of obese DIO 
dams reared on a HFD, develop obesity when fed a chow diet (Levin and Govek, 1998). Using 
this model, Simerly and Bouret have shown that such obesity-prone offspring have fewer leptin-
sensing neurons in the ARH compared to controls (Bouret et al., 2008). Because AgRP and a 
subset of POMC neurons are leptin-sensing, we anticipate that the composition of these two 
populations may be biased in this model and thus the lineage giving rise to the leptin-sensing 
terminal identity may be of critical importance to the composition of ARH neurons. 
In conclusion, it is likely that Pomc expression in the embryo plays a functional role in the 
proliferation and differentiation of ARH cell types. We are pursuing these possibilities as noted 
in Chapter 4 using a Pomc-/- model. Along with this, data has shown that POMC neurons in the 
ARH differ in many physiologic properties; it is likely that some of these subsets are derived 
from unique progenitor pools. Findings in the recent literature support to idea that subsets of 
POMC and NPY/AgRP neurons are derived from a common lineage, and also that the maternal 
nutrient environment can influence this common progenitor to bias the establishment of 
orexigenic tone in the ARH ((Carmody et al., 2010; Pelling et al., 2010), and Bouret 
unpublished). Utilizing reagents and techniques to map various functional and lineage markers 
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to Pomc and Npy-expressing populations in the mature ARH, should provide useful to resolve a 
conclusive model depicting the ontogeny of cell types in the ARH. These studies provide a 
critical foundation for efforts to understand how the maternal environment can influence 







Fig. 5.4. Candidate lineage of a leptin-sensing ARH terminal fate. (A) Double FISH/IHC 
against Pomc/Npy (red) and PSTAT3 (white); note independent populations of both red and 
white exist in the ARH. (B) Theoretical model. Abbreviations: N, NPY neurons; P, POMC 
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APPENDIX A: Screen for Lineage Markers of the Arcuate Nucleus of the Hypothalamus 
Overview 
A growing body of evidence supports that POMC and AgRP neurons in the ARH are not 
homogenous. Both electrophysiological recordings and histological expression analysis reveal 
discrete subpopulations of both POMC and AgRP neurons (de Souza et al., 2011; Fioramonti et 
al., 2007; Hentges et al., 2004; Hentges et al., 2009; Murphy et al., 2009; Parton et al., 2007; 
Williams et al., 2010). The elucidation of genetic reagents for distinct POMC and AgRP 
homogenous subpopulations will be paramount to defining the physiologic relevance of these 
subsets and may.  
In this study we sought to define molecular markers of NPY/AgrP and POMC subsets, which 
can be used as tools to target and investigate the physiologic contribution of each homogenous 
subset. It is known that specification of cellular identity relies on intrinsic activation of genetic 
programs by unique combinations of transcription factors and therefore select transcription 
factors can act as signatures (lineage markers) for distinct populations  (Edlund and Jessell, 
1999). Using public expression databases and the literature searches we identified 295 
transcription factors present in the ARH (Gong et al., 2003; Jing et al., 2004; Lein et al., 2007; 
Su et al., 2004; Visel et al., 2004). To narrow this pool down to lineage marker candidates, we 
then segregated our selection based on two main criteria: 1) expression patterns relatively 
restricted to the ARH, and 2) expression that was consistent across a broad range of 
developmental stages, leaving us with 65 candidate transcription factor lineage markers.  
To describe the regional specificity of all 65 transcription factors, we developed ribo-probes 
and mapped each on cryo-sections of the ARH (note: probes were designed in consideration of 
known splice variants). For each probe, we initially performed an in-situ hybridization (ISH) 
alkaline phosphatase (AP) stain on sections from both adult and P7 brains. From this, we 
determined that 29 transcription factors of the 65 candidates were expressed at sufficient levels 
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to define distinct cellular expression and also presented a similar pattern of expression at both 
P7 and adult stages (Table A.1). The expression of these 29 candidates with respect to Npy- 
and Pomc-expressing populations was performed using two-color FISH and shown in Table A1. 
We did not find any markers to exclusively reside in subsets of either Npy or Pomc cells in the 
ARH, which may reflect that the lineage of these populations is not restricted to an NPY or 






NPY POMC Other 
Markers Pan Subset Pan Subset ARH 
BarH1         x 
BarX2         x 
Bsx x         
Dlx1         x  
Dlx5   x     x 
Dlx6   x   x x 
Elk1   x   x x 
Ets1         x 
Etv1/ER81       x x 
Fatso x   x   x 
Fhl2 x       x 
Lhx2         vz+other 
Lhx5         x 
Lhx9   x   x x 
Lim1         x 
Lrrn3       x x 
Nhlh2   x   x x 
Nkx2.4         vz, x 
Nr3c1   x     x 
Otp x   x   x 
Peg3 x   x   x 
Six1         x 
Six3         vz, x 
Six4 x       x 
Six6         x 
Sox9 x       vz, x 
Tbx3     x   x 
Tbx19   x   x x 






Animals were housed in temperature controlled rooms at 21 °C and subject to a 12 h light-
dark cycle. Mice had ad libitum access to standard chow diet (Lab Diet: PicoLab Rodent Diet 
5053) and water. C57BL/6 mice  were obtained from the Jackson Laboratory and bred at the 
Russ Berrie Animal Facility. All procedures were performed in accordance with the guidelines of 
the Institutional Animal Care and Use Committee at the Columbia University Health Sciences 
Division. 
Fluorescent In Situ Hybridization 
Tissue Processing: FISH: Adult mice were anesthetized and perfused transcardially with 
0.9% NaCl followed by 4% paraformaldehyde (PFA) in phosphate buffer (PB). Brains were post-
fixed at 4°C overnight and cryoprotected with 30% sucrose for 48 h. For embryonic tissue, dams 
were anesthetized with Avertin and embryos were dissected in cold PBS and fixed at 4 °C 
overnight and cryoprotected with 30% sucrose for 24 h. Tissue was embedded in O.C.T (Tissue 
Tek) and frozen at –80°C. 10 µm-thick coronal sections were collected across the rostral–
caudal extent of the ARH on Superfrost Plus slides (Fisher).  
FISH: Frozen sections were processed as described in the TSA Plus Cy3 System manual 
(Perkin Elmer).  Antisense digoxigenin- and fluorescence-labeled riboprobes were generated 





















Ets1-F 5’-TAGGGTTGCGCTCTGTCC  
Ets1-R 5’-ATGACTGGCTGCTCCAGG  
Etv1/Er81-F 5’-GTGCCTCTGTCTCACTTTGATG 



























Six1-F 5’- CTCGGTCCTTCTGCTCCA  







Tbx19-F 5’-CCAGCATGTGACCTACTCTCAC  
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